<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName ACSJournal-v102.dtd?><?SourceDTD.Version 1.02?><?ConverterInfo.XSLTName acs2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">ACS Nano</journal-id><journal-id journal-id-type="iso-abbrev">ACS Nano</journal-id><journal-id journal-id-type="publisher-id">nn</journal-id><journal-id journal-id-type="coden">ancac3</journal-id><journal-title-group><journal-title>ACS Nano</journal-title></journal-title-group><issn pub-type="ppub">1936-0851</issn><issn pub-type="epub">1936-086X</issn><publisher><publisher-name>American Chemical Society</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7263075</article-id><article-id pub-id-type="doi">10.1021/acsnano.0c03822</article-id><article-categories><subj-group><subject>Article</subject></subj-group></article-categories><title-group><article-title>Selective Naked-Eye Detection of SARS-CoV-2 Mediated by N Gene Targeted
Antisense Oligonucleotide Capped Plasmonic Nanoparticles</article-title></title-group><contrib-group><contrib contrib-type="author" id="ath1"><name><surname>Moitra</surname><given-names>Parikshit</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="notes2" ref-type="notes">#</xref></contrib><contrib contrib-type="author" id="ath2"><name><surname>Alafeef</surname><given-names>Maha</given-names></name><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff3" ref-type="aff">&#x000a7;</xref><xref rid="notes2" ref-type="notes">#</xref></contrib><contrib contrib-type="author" id="ath3"><name><surname>Dighe</surname><given-names>Ketan</given-names></name><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><contrib contrib-type="author" id="ath4"><name><surname>Frieman</surname><given-names>Matthew B.</given-names></name><xref rid="aff5" ref-type="aff">&#x022a5;</xref></contrib><contrib contrib-type="author" corresp="yes" id="ath5"><name><surname>Pan</surname><given-names>Dipanjan</given-names></name><xref rid="cor1" ref-type="other">*</xref><xref rid="aff1" ref-type="aff">&#x02020;</xref><xref rid="aff2" ref-type="aff">&#x02021;</xref><xref rid="aff4" ref-type="aff">&#x02225;</xref></contrib><aff id="aff1"><label>&#x02020;</label>Departments of Diagnostic Radiology and Nuclear
Medicine and Pediatrics, Center for Blood Oxygen Transport and Hemostasis,
<institution>University of Maryland Baltimore School of Medicine</institution>, Health
Sciences Facility III, 670 West Baltimore Street, Baltimore, Maryland 21201,
<country>United States</country></aff><aff id="aff2"><label>&#x02021;</label>Bioengineering Department, <institution>University of
Illinois at Urbana&#x02212;Champaign</institution>, Urbana, Illinois 61801,
<country>United States</country></aff><aff id="aff3"><label>&#x000a7;</label>Biomedical Engineering Department, <institution>Jordan
University of Science and Technology</institution>, Irbid 22110,
<country>Jordan</country></aff><aff id="aff4"><label>&#x02225;</label>Department of Chemical, Biochemical, and Environmental
Engineering, <institution>University of Maryland Baltimore County</institution>,
Interdisciplinary Health Sciences Facility, 1000 Hilltop Circle, Baltimore, Maryland
21250, <country>United States</country></aff><aff id="aff5"><label>&#x022a5;</label>Department of Microbiology and Immunology,
<institution>University of Maryland School of Medicine</institution>, 685 West Baltimore
Street, Baltimore, Maryland 21201, <country>United States</country></aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Email:
<email>dipanjan@som.umaryland.edu</email>.</corresp></author-notes><pub-date pub-type="epub"><day>21</day><month>05</month><year>2020</year></pub-date><elocation-id>acsnano.0c03822</elocation-id><history><date date-type="received"><day>07</day><month>05</month><year>2020</year></date><date date-type="accepted"><day>21</day><month>05</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 American Chemical Society</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>American Chemical Society</copyright-holder><license license-type="open-access"><license-p>This article is made available via the PMC Open Access Subset for unrestricted RESEARCH
re-use and analyses in any form or by any means with acknowledgement of the original
source. These permissions are granted for the duration of the World Health Organization
(WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract><p content-type="toc-graphic"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nn0c03822_0009" id="ab-tgr1"/></p><p>The current outbreak of the pandemic coronavirus disease 2019 (COVID-19) caused by the
severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) demands its rapid,
convenient, and large-scale diagnosis to downregulate its spread within as well as
across the communities. But the reliability, reproducibility, and selectivity of
majority of such diagnostic tests fail when they are tested either to a viral load at
its early representation or to a viral gene mutated during its current spread. In this
regard, a selective &#x0201c;naked-eye&#x0201d; detection of SARS-CoV-2 is highly
desirable, which can be tested without accessing any advanced instrumental techniques.
We herein report the development of a colorimetric assay based on gold nanoparticles
(AuNPs), when capped with suitably designed thiol-modified antisense oligonucleotides
(ASOs) specific for N-gene (nucleocapsid phosphoprotein) of SARS-CoV-2, could be used
for diagnosing positive COVID-19 cases within 10 min from the isolated RNA samples. The
thiol-modified ASO-capped AuNPs agglomerate selectively in the presence of its target
RNA sequence of SARS-CoV-2 and demonstrate a change in its surface plasmon resonance.
Further, the addition of RNaseH cleaves the RNA strand from the RNA&#x02013;DNA hybrid
leading to a visually detectable precipitate from the solution mediated by the
additional agglomeration among the AuNPs. The selectivity of the assay has been
monitored in the presence of MERS-CoV viral RNA with a limit of detection of 0.18
ng/&#x003bc;L of RNA having SARS-CoV-2 viral load. Thus, the current study reports a
selective and visual &#x0201c;naked-eye&#x0201d; detection of COVID-19 causative virus,
SARS-CoV-2, without the requirement of any sophisticated instrumental techniques.</p></abstract><kwd-group><kwd>gold nanoparticle</kwd><kwd>naked-eye detection</kwd><kwd>COVID-19</kwd><kwd>antisense oligonucleotide</kwd><kwd>hyperspectral imaging</kwd><kwd>SARS-CoV-2</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>document-id-old-9</meta-name><meta-value>nn0c03822</meta-value></custom-meta><custom-meta><meta-name>document-id-new-14</meta-name><meta-value>nn0c03822</meta-value></custom-meta><custom-meta><meta-name>ccc-price</meta-name><meta-value/></custom-meta></custom-meta-group></article-meta></front><body><p id="sec1">An unexpected outbreak of coronavirus disease 2019 (COVID-19) has collapsed many health
care systems and crashed numerous economies. The disease was first identified in December
2019 and has since rapidly spread across the world, resulting in the ongoing 2019&#x02013;20
pandemic.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> It has filled hospitals and emptied public spaces while
disrupting a modern society on a scale that most people in the world have never witnessed in
their lifetime.<sup><xref ref-type="bibr" rid="ref2">2</xref>&#x02212;<xref ref-type="bibr" rid="ref4">4</xref></sup> Like most of the previous
modern epidemics and pandemics, this newly emerging infectious disease is caused by the
novel severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2)
virus.<sup><xref ref-type="bibr" rid="ref5">5</xref>,<xref ref-type="bibr" rid="ref6">6</xref></sup> The
COVID-19 pandemic is believed to have close similarities with severe acute respiratory
syndrome (SARS) and the Middle East respiratory syndrome (MERS) in terms of causing severe
acute respiratory distress.<sup><xref ref-type="bibr" rid="ref7">7</xref>,<xref ref-type="bibr" rid="ref8">8</xref></sup> An average of two or three people are getting infected from every
already affected person because of the higher transmission rate for
COVID-19.<sup><xref ref-type="bibr" rid="ref9">9</xref>&#x02212;<xref ref-type="bibr" rid="ref11">11</xref></sup> The efforts to contain the
virus are ongoing, but considering the many uncertainties regarding the pathogen
transmissibility and virulence the efficacy of these efforts is unknown. A crucial
shortcoming of the healthcare systems across the globe has been the ability to rapidly and
accurately diagnose the disease with contributing factors that include a shortage of test
kits and specimen materials, availability of personal protective equipment and reagents,
limited certified testing centers, and no established funding mechanism to support these
testing facilities.<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> Further, the lack of rapid diagnostic tests along
with the inaccessibility of the advanced instrumental techniques to all the diagnostic
centers, especially the remote ones, contribute to the confusion surrounding which
individuals should be quarantined, limit epidemiological data, and the ability to track
pathogen transmission within as well as across communities. Therefore, a key part for the
management of COVID-19 pandemic lies in &#x0201c;flattening the curve&#x0201d;, that is,
decreasing the epidemic peak, through different measures taken for reducing the rate of new
infections.<sup><xref ref-type="bibr" rid="ref13">13</xref>,<xref ref-type="bibr" rid="ref14">14</xref></sup></p><p>The ability to perform pervasive testing has already shown benefits to countries such as
South Korea and Singapore,<sup><xref ref-type="bibr" rid="ref15">15</xref>,<xref ref-type="bibr" rid="ref16">16</xref></sup> providing precise information about mandatory quarantine for a carrier
of the virus and rigorous contract tracing which in turn results in greater control in
slowing the spread of the disease. Downmodulating the infection rate will therefore help to
minimize the risk of overwhelming health facilities, allowing faster care of existing cases
and delaying new cases before therapeutics or a vaccine are available.<sup><xref ref-type="bibr" rid="ref17">17</xref>&#x02212;<xref ref-type="bibr" rid="ref20">20</xref></sup> At present, COVID-19 is
being primarily diagnosed by three techniques: (1) reverse-transcription polymerase chain
reaction (RT-PCR) and gene sequencing; (2) a lateral flow immunoassay, which is a common
point-of-care (POC) diagnostic approach that detects antibodies against SARS-CoV-2 in
patient samples; and (3) chest computed tomography (CT). Out of these, chest CT has been
identified as a major screening tool, if available.<sup><xref ref-type="bibr" rid="ref21">21</xref>,<xref ref-type="bibr" rid="ref22">22</xref></sup> Moreover, the current gold standard approach for
screening COVID-19 requires access to reverse transcriptase real-time PCR assay (RT-PCR),
which can be carried out using a variety of clinical specimens, including blood, feces,
bronchoalveolar lavage fluid, sputum, fiber bronchoscope brush biopsies, nasal swabs, or
pharyngeal swabs.<sup><xref ref-type="bibr" rid="ref23">23</xref>,<xref ref-type="bibr" rid="ref24">24</xref></sup> On
the basis of this technique, numerous laboratories have developed experimental protocols
using quantitative RT-PCR (qRT-PCR) methods for virus identification within 4&#x02013;6 h,
including a test developed by U.S. Centers for Disease Control and Prevention (CDC) and
approved under emergency use authorization (EUA) process.<sup><xref ref-type="bibr" rid="ref25">25</xref></sup> However,
limitations of sample collection and transportation, as well as the performance of the kit
with inadequate access to advanced instrumental techniques, often cannot report positive
COVID-19 cases at its initial presentation leading to the spread of this infectious disease
to a wider community. Furthermore, traveling to a clinical setting for testing increases the
risk of spreading the SARS-CoV-2 virus which further adds strain to a resource-limited
healthcare system. Additionally, while serological tests are rapid, POC, and require minimal
equipment, their efficacy may be limited in the diagnosis of acute SARS-CoV-2 infection
only, as it may take several days to weeks after the onset of the symptom for a patient to
develop a detectable antibody response.<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> Therefore, as some of the
existing techniques remain laborious and technically challenging, there is an urgent unmet
need for a POC, rapid, cost-effective, and selective diagnostic test for COVID-19 that can
provide fast and accurate test results within a duration of less than an hour and possibly
within minutes.<sup><xref ref-type="bibr" rid="ref27">27</xref></sup></p><p>Nanotechnology-based colorimetric bioassays are convenient and attractive in biosensor
design for their simplicity, visual output, and no necessity for complex
instruments.<sup><xref ref-type="bibr" rid="ref28">28</xref>&#x02212;<xref ref-type="bibr" rid="ref32">32</xref></sup> In recent
years, gold nanoparticle (AuNPs) have garnered incredible attention in the field of
colorimetric-based biosensing applications due to their exceptional optical properties such
as high extinction coefficient, localized surface plasmon resonance, and inherent
photostability.<sup><xref ref-type="bibr" rid="ref33">33</xref>,<xref ref-type="bibr" rid="ref34">34</xref></sup>
They have been utilized in numerous colorimetric-based biosensing applications to detect a
wide range of chemical and biological targets like small molecules, proteins, metal ions,
and nucleic acids where the particle changes its color in response to the reactivity of the
nanosized particles to the external conditions.<sup><xref ref-type="bibr" rid="ref35">35</xref>&#x02212;<xref ref-type="bibr" rid="ref43">43</xref></sup> Despite these features,
however, this technique still involves the preparation of ssDNA probes and the
implementation of several intermediate steps, such as time-intensive denaturation and
annealing after PCR.<sup><xref ref-type="bibr" rid="ref44">44</xref></sup> Furthermore, given that both ssDNA and dsDNA
stabilize the AuNPs at low salt concentrations, cationic agents are primarily required to
detect the target with probes. A colorimetric bioassay was thus developed for the detection
of DNA/RNA targets based on unmodified AuNP aggregation using disulfide self-assembly of
terminal modified DNA.<sup><xref ref-type="bibr" rid="ref45">45</xref></sup> The products generated in this approach not only
demonstrated a high affinity for the surface of AuNPs but also protected them efficiently
from salt-induced aggregation. Additionally, a colorimetric assay based on a similar
approach was also reported to detect the presence of Middle East respiratory syndrome
coronavirus (MERS-CoV).<sup><xref ref-type="bibr" rid="ref46">46</xref></sup></p><p>Accordingly, we realized the importance of nanotechnology in controlling the spread of
COVID-19<sup><xref ref-type="bibr" rid="ref47">47</xref>&#x02212;<xref ref-type="bibr" rid="ref49">49</xref></sup> and utilized its exclusive
features in developing a colorimetric assay based on AuNPs. These AuNPs, when capped with
suitably designed thiol-modified antisense oligonucleotides (ASOs) specific for N-gene
(nucleocapsid phosphoprotein) of SARS-CoV-2, could potentially be used for diagnosing
positive COVID-19 cases within a few minutes. The methodology, described herein, utilizes an
all-inclusive targeting approach mediated by four of the ASO sequences covering two regions
of the viral N-gene sequence at the same time. These thiolated ASO-capped AuNPs agglomerate
only in the presence of its target RNA sequence of SARS-CoV-2 and thus demonstrate a change
in its surface plasmon resonance (SPR), which is further amplified with the addition of
RNaseH leading to the visually detectable precipitation of gold nanoparticles (<xref rid="sch1" ref-type="scheme">Scheme <xref rid="sch1" ref-type="scheme">1</xref></xref>). The agglomeration of ASO-capped gold
nanoparticles in the presence of SARS-CoV-2 RNA was studied by UV&#x02013;visible absorbance
spectroscopy, transmission electron microscopy (TEM), and enhanced dark-field hyperspectral
imaging technique. Thus, the current study utilizes the intrinsic optical properties of
plasmonic AuNPs and targeting ability of the ASOs to develop a selective, and
&#x0201c;naked-eye&#x0201d; detection platform for the current COVID-19 causative virus,
SARS-CoV-2, without the requirement of any expensive instrumental techniques. The
reliability and reproducibility of the current biosensor increases based on its design of
simultaneous targeting of two of the N-gene regions of SARS-CoV-2, ensuring the feasibility
of the assay even if one region of the viral gene undergoes mutation during its current
spread.</p><fig id="sch1" position="float"><label>Scheme 1</label><caption><title>Schematic Representation for the Selective Naked-Eye Detection of SARS-CoV-2 RNA
Mediated by the Suitably Designed ASO-Capped AuNPs</title></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nn0c03822_0008" id="gr8" position="float"/></fig><sec id="sec2"><title>Results and Discussion</title><sec id="sec2.1"><title>Strategy Behind the Sensor Development</title><p>During the current spread of COVID-19 causative virus, SARS-CoV-2, scientists have
discovered three regions among the SARS-related viral genomes that had conserved
sequences. These sequences are (a) <italic>RdRP</italic> gene (RNA-dependent RNA
polymerase gene) responsible for the open reading frame ORF1ab region, (b)
<italic>E</italic> gene (envelope protein gene), and (c) <italic>N</italic> gene
(nucleocapsid phosphoprotein gene).<sup><xref ref-type="bibr" rid="ref26">26</xref></sup> The analytical sensitivity of
both the <italic>RdRP</italic> and <italic>E</italic> genes was demonstrated to be quite
high (technical limit of detection of 3.6 and 3.9 copies per reaction), while the
sensitivity for <italic>N</italic> gene was observed to be weaker (8.3 copies per
reaction). This leaves an enormous area for the improvement of biosensors targeted for
<italic>N</italic> gene sequence of SARS-CoV-2. Statistically, a sensitive biosensor
selectively targeting the <italic>N</italic> gene sequence of SARS-CoV-2 with a visual
naked-eye response without the need for access to any sophisticated instrumental
techniques would greatly benefit the current sensor development research for COVID-19. In
addition to this, the analytical sensitivity of the biosensor can be improved by
simultaneous targeting of multiple genetic regions within the same gene sequence, which
will add to features of the biosensor. This will also increase the feasibility of the
assay even if one region of the viral gene undergoes mutation during its current spread.
We therefore targeted <italic>N</italic> gene sequence of SARS-CoV-2 and undertook gold
nanoparticle as one of the important anisotropic plasmonic nanostructures for the
development of a COVID-19 specific biosensor.<sup><xref ref-type="bibr" rid="ref33">33</xref></sup></p></sec><sec id="sec2.2"><title>Design and Selection of Antisense Oligonucleotides (ASOs)</title><p>The <italic>N</italic> gene was commenced herein as the target gene sequence for the
selective detection of SARS-CoV-2 isolate 2019-nCoV/USA-WA1-A12/2020 (detailed sequence
has been provided in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Supporting Information</ext-link>), and a set of ASOs were predicted following a
methodology as described in <xref rid="sec4" ref-type="other">Materials and Methods</xref>. Among the
predicted ASO sequences, four of the ASOs were selected based on their comparative binding
disruption energies and binding energies with the target sequence (<xref rid="tbl1" ref-type="other">Table
<xref rid="tbl1" ref-type="other">1</xref></xref>). One of the other parameters behind the selection of these
four ASO sequences was their closely following target position. The ASOs were then
differentially functionalized: ASO1 and ASO3 were functionalized with thiol moiety at the
5&#x02032; end, whereas ASO2 and ASO4 were functionalized with thiol moiety at the
3&#x02032; end (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>a). These ASOs when used
to cap gold nanoparticles are expected to become agglomerated selectively in the presence
of the <italic>N</italic> gene sequence of SARS-CoV-2 which can be corroborated with their
complementary binding followed by aggregation propensity among the nanoparticles (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>b).</p><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><title>Selected ASO Sequences Targeted for the N-Gene of SARS-CoV-2</title></caption><table frame="hsides" rules="groups" border="0"><colgroup><col align="left"/><col align="char" char="."/><col align="left"/><col align="left"/><col align="char" char="."/><col align="char" char="."/><col align="char" char="."/></colgroup><thead><tr><th style="border:none;" align="center">starting target position</th><th style="border:none;" align="center" char=".">ending target position</th><th style="border:none;" align="center">target sequence (5p&#x000a0;&#x02192;&#x000a0;3p)</th><th style="border:none;" align="center">antisense oligo (5p&#x000a0;&#x02192;&#x000a0;3p)</th><th style="border:none;" align="center" char=".">GC content</th><th style="border:none;" align="center" char=".">binding site disruption energy (kcal/mol)</th><th style="border:none;" align="center" char=".">binding energy (kcal/mol)</th></tr></thead><tbody><tr><td style="border:none;" align="left">421</td><td style="border:none;" align="char" char=".">440</td><td style="border:none;" align="left">ACACCAAAAGAUCACAUUGG</td><td style="border:none;" align="left">CCAATGTGATCTTTTGGTGT (<bold>ASO1</bold>)</td><td style="border:none;" align="char" char=".">40.0%</td><td style="border:none;" align="char" char=".">7.6</td><td style="border:none;" align="char" char=".">&#x02013;15.8</td></tr><tr><td style="border:none;" align="left">443</td><td style="border:none;" align="char" char=".">462</td><td style="border:none;" align="left">CCCGCAAUCCUGCUAACAAU</td><td style="border:none;" align="left">ATTGTTAGCAGGATTGCGGG (<bold>ASO2</bold>)</td><td style="border:none;" align="char" char=".">50.0%</td><td style="border:none;" align="char" char=".">7.6</td><td style="border:none;" align="char" char=".">&#x02013;10.4</td></tr><tr><td style="border:none;" align="left">836</td><td style="border:none;" align="char" char=".">855</td><td style="border:none;" align="left">CAGAACAAACCCAAGGAAAU</td><td style="border:none;" align="left">ATTTCCTTGGGTTTGTTCTG (<bold>ASO3</bold>)</td><td style="border:none;" align="char" char=".">40.0%</td><td style="border:none;" align="char" char=".">6.0</td><td style="border:none;" align="char" char=".">&#x02013;14.3</td></tr><tr><td style="border:none;" align="left">886</td><td style="border:none;" align="char" char=".">905</td><td style="border:none;" align="left">ACUGAUUACAAACAUUGGCC</td><td style="border:none;" align="left">GGCCAATGTTTGTAATCAGT (<bold>ASO4</bold>)</td><td style="border:none;" align="char" char=".">40.0%</td><td style="border:none;" align="char" char=".">8.7</td><td style="border:none;" align="char" char=".">&#x02013;10.0</td></tr></tbody></table></table-wrap><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Differentially functionalized ASOs with their sequences are represented in (a). The
proposed concept behind the agglomeration of gold nanoparticles, when capped with the
ASOs, is schematically presented in (b).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nn0c03822_0001" id="gr1" position="float"/></fig></sec><sec id="sec2.3"><title>Standardization of the ASO-Capped AuNPs for the Sensitive Detection of
SARS-CoV-2</title><p>Accordingly, the differentially functionalized thiol-modified ASOs were utilized to
exchange the surface capping agent of the citrate stabilized gold nanoparticles. The TEM
images (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>a,b) show that the ASO-capped
AuNPs are individually dispersed with no visible aggregation. All of the four ASO-capped
AuNPs exhibit a small anhydrous size of &#x0003c;30 nm, which are well dispersed without the
formation of a large entity. <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>c shows the
average hydrodynamic sizes of the four individual ASO-capped gold nanoparticles, which
were found to be less than 60 nm. The formation of ASO-conjugated thiol-stabilized AuNPs
was further confirmed from their surface plasmon bands.<sup><xref ref-type="bibr" rid="ref50">50</xref></sup> Two
absorption peaks, one at &#x0223c;530 nm and the other at &#x0223c;620 nm, were observed
after the thiol-modified ASO capping on the surface of the AuNPs (<xref rid="fig2" ref-type="fig">Figure
<xref rid="fig2" ref-type="fig">2</xref></xref>d).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>(a) TEM image of ASO-capped gold nanoparticles. (b) Zoomed-in TEM images of
Au-ASO<sub>mix</sub> nanoparticles with the individual ASO-capped AuNPs are shown as
insets. (c) Comparative change in hydrodynamic diameter of the gold nanoparticles
capped with individual ASOs and the mixture of the four Au-ASOs. Error bar indicates
the measurements of hydrodynamic diameter from three such independent experiments. (d)
Normalized change in absorbance of the gold nanoparticles before and after the
addition of thiol modified ASOs to the citrate stabilized ones.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nn0c03822_0002" id="gr2" position="float"/></fig><p>The relative sensitivity of the various ASO-capped gold nanoparticles toward the target
SARS-CoV-2 RNA was then monitored with the comparative increase in absorbance at 660 nm.
It was observed that the surface capping of thiol-modified ASOs together with the
comparative ratio of the ASOs to the AuNPs (ASO/AuNPs) play a major role in determining
the sensitivity of the gold nanoparticles toward SARS-CoV-2 RNA. To investigate the effect
of the ASO/AuNPs ratio on the sensitivity of the sensing platform, three different ratios
of ASO/AuNPs have been tested. The ratios are named as the following: high
(ASO<sub>H</sub>), medium (ASO<sub>M</sub>), and low (ASO<sub>L</sub>) concentrations
for the four ASOs; see <xref rid="sec4" ref-type="other">Materials and Methods</xref> for details. Among
these 12 different combinations of the ASO-conjugated AuNPs, which vary in the ratio of
ASO/AuNPs, ASO<sub>M</sub> was found the most sensitive ratio for the AuNPs capped with
ASO1 (i.e., Au-ASO<sub>1M</sub>). However, among ASO2<sub>,</sub> the low ratio was found
to be the most sensitive in detecting the viral RNA (Au-ASO<sub>2L</sub>), the high ratio
in ASO3 (Au-ASO<sub>3H</sub>), and finally the medium in ASO4 (Au-ASO<sub>4M</sub>) (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>).</p><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Increase in absorbance at 660 nm for the gold nanoparticles coated with different
concentrations of (a) ASO<sub>1</sub>, (b) ASO<sub>2</sub>, (c) ASO<sub>3</sub>, and
(d) ASO<sub>4</sub> upon the addition of SARS-CoV-2 RNA. The RNA concentration kept
constant at 1 ng/&#x003bc;L throughout the experiment. The mixture was incubated for 15
min at room temperature prior to recording the change in absorbance in each case.
Error bar indicates the average results obtained from three independent experiments
performed in triplicate.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nn0c03822_0003" id="gr3" position="float"/></fig><p>After optimizing the ASO to AuNPs ratio to obtain the maximum sensitivity, all four of
the ASO-capped AuNPs (i.e., Au-ASO<sub>1M</sub>, Au-ASO<sub>2L</sub>, Au-ASO<sub>3H</sub>,
and Au-ASO<sub>4M</sub>) were mixed (Au-ASO<sub>mix</sub>) in an equivalent amount with
each other to further improve the analytical sensitivity of the gold nanoparticles toward
SARS-CoV-2 RNA. Transmission electron microscopy indicated the formation of distinctly
dispersed AuNPs (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>b) with the average
hydrodynamic diameter of about 55.4 &#x000b1; 4.5 nm as observed from Zetaview (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>c and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_002.mp4">Movie S1</ext-link>). It was expected that the agglomeration propensity among the
nanoparticles would increase when treated in a composite manner (Au-ASO<sub>mix</sub>)
with the SARS-CoV-2 RNA. A large redshift of about 40 nm in the aggregation band was also
observed when the Au-ASO<sub>mix</sub> nanoparticles were tested against the SARS-CoV-2
RNA (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>a). The improvement in analytical
sensitivity of Au-ASO<sub>mix</sub> nanoparticles toward the detection of SARS-CoV-2 viral
RNA was further validated by monitoring the relative increase in absorbance at 660 nm in
comparison with individual ASO-capped AuNPs (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Figure S1</ext-link>). The analytical performance of the sensor was also probed when
two of the ASO-capped AuNPs were mixed instead of all four (Au-ASO<sub>mix</sub>). The
choice of two of the ASO-capped AuNPs (either Au-ASO<sub>1M+2L</sub> or
Au-ASO<sub>3H+4M</sub>) was based on their proximity to target one of the regions of
<italic>N</italic> gene sequence. In all cases, it was observed that
Au-ASO<sub>mix</sub> was the optimum formulation to target SARS-CoV-2 RNA with higher
sensitivity than the other sensors tested herein.</p><fig id="fig4" position="float"><label>Figure 4</label><caption><p>(a) Normalized change in absorbance of the gold nanoparticles before and after the
addition of total RNA containing the SARS-CoV-2 viral load. (b) Comparative change in
average hydrodynamic diameter of the composite of Au-ASO<sub>mix</sub> before and
after the addition of RNA containing SARS-CoV-2 where the RNA concentration was varied
from 0.1 to 0.5 and 1 ng/&#x003bc;L. Error bar indicates the measurements of
hydrodynamic diameter from three such independent experiments. (c&#x02013;f) TEM images
of the Au-ASO<sub>mix</sub> nanoparticles after addition of RNA containing SARS-CoV-2.
(g) The percent change in absorbance at 660 nm of the ASO-capped gold nanoparticles at
different incubation time points with a definite concentration of 1 ng/&#x003bc;L RNA.
Here, the error bar indicates the average results obtained from four such independent
experiments performed in triplicates.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nn0c03822_0004" id="gr4" position="float"/></fig><p>Interestingly, as per our hypothesis, the Au-ASO<sub>mix</sub> nanoparticles were
confirmed to be individually dispersed in the sample in absence of the viral load, which
in the presence of SARS-CoV-2 RNA tend to agglomerate forming large clusters. The
aggregation of AuNPs was confirmed from the increase in absorbance of the aggregation band
at 660 nm<sup><xref ref-type="bibr" rid="ref51">51</xref>&#x02212;<xref ref-type="bibr" rid="ref53">53</xref></sup> when the
Au-ASO<sub>mix</sub> nanoparticles were exposed to a definite concentration of total RNA
(1 ng/&#x003bc;L) extracted from the Vero cells infected with SARS-CoV-2 with an incubation
time of 15 min at room temperature. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Table S1</ext-link> represents a comparative overview of change in average hydrodynamic
diameter (<italic>D</italic><sub>ah</sub>), as observed from Zetaview, and average size of
the aggregated nanoparticles, as measured from the TEM analyses, for the
Au-ASO<sub>mix</sub> nanoparticle before and after addition of its target SARS-CoV-2
viral RNA. It was evident that there was minimal change in hydrodynamic diameters when the
individual ASO-capped AuNPs were mixed with each other (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>c). But the hydrodynamic diameter of Au-ASO<sub>mix</sub>
nanoparticles increased largely with the addition of its target RNA containing SARS-CoV-2
(<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>b). This indicated the enhanced
propensity of the nanoparticles to aggregate in the presence of its target RNA containing
SARS-CoV-2. The screenshots as observed from ZetaView are shown in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_003.mp4">Movie S2</ext-link>.</p><p>This response of Au-ASO<sub>mix</sub> nanoparticles to its target viral RNA was further
corroborated by the TEM images. A significant amount of clustering was found among the
nanoparticles in the presence of their target viral RNA (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>c&#x02013;f). The formation of both large (&#x0223c;120 nm) and small
(&#x0223c;80 nm) gold nanoparticle entities was observed in the sample. It was also
monitored that the optimum sensitivity was achieved within 4&#x02013;6 min of incubation at
room temperature of the nanoparticles with the total RNA (1 ng/&#x003bc;L) extracted from
the Vero cells infected with SARS-CoV-2 (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>g). To further investigate the sensitivity of Au-ASO<sub>mix</sub> and the
selective agglomeration of the nanoparticles in the presence of the viral SARS-CoV-2 RNA,
we visualized the particles under enhanced dark-field hyperspectral imaging microscope.
The hyperspectral imaging (HSI) provided a label-free detection approach, combining both
imaging and spectrophotometry, that can be used to localize nanomaterial based on their
hyperspectral signature.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> The HSI system utilizes advanced optics and
computational algorithms to capture a spectrum from 400 to 1000 nm at each pixel of the
image with an enhanced dark-field microscope (EDFM). The obtained spectrum represents a
signature of each individual material that can be used to confirm the identity of the
materials of interest in a mixture of the sample. This information can further be utilized
to create an image &#x0201c;map&#x0201d; to reveal the presence and location of material of
interest in the targeted sample. EDFM-HSI mapping thus proves to be an accurate technique
that could locate and identify nanomaterials in samples more efficiently when compared to
other conventional techniques.<sup><xref ref-type="bibr" rid="ref54">54</xref>,<xref ref-type="bibr" rid="ref55">55</xref></sup></p><p><xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>a illustrates the EDFM-HSI image of the
Au-ASO<sub>mix</sub> nanoparticles in the absence of its target SARS-CoV-2 RNA.
Consistent with our previous results, the AuNPs in the Au-ASO<sub>mix</sub> were found to
be well dispersed with insignificant aggregation propensity among the AuNPs. <xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>b shows the average spectrum of the
hyperspectral signal of all the AuNPs that existed in the dark-field image (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Figure S2</ext-link>). After the addition of the RNA having SARS-CoV-2 viral gene, a
significant number of clustered gold nanoparticles were observed in the sample indicating
the enhanced propensity among the nanoparticles to aggregate which is consistent with the
previous TEM, Zetaview, and optical absorbance results (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>c). The agglomeration propensity among the AuNPs in the presence of
its target viral RNA can thus be related to the precise designing, targeting ability and
binding affinity of the ASOs with their target gene. A significant change in the
hyperspectral signature of the sample has been found where a sharp peak has been observed
after the addition of the viral RNA. Further, in the presence of the viral RNA we observed
broadening in the average spectral signature with a redshift in the spectrum tail (<xref rid="fig5" ref-type="fig">Figures <xref rid="fig5" ref-type="fig">5</xref></xref>d and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">S2</ext-link>). Multiples of such hyperspectral images of Au-ASO<sub>mix</sub>
nanoparticles conjugated with SARS-CoV-2 RNA are represented in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Figure S3</ext-link> and <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_004.mp4">Movie S3</ext-link>.</p><fig id="fig5" position="float"><label>Figure 5</label><caption><p>EDFM-HSI of the Au-ASO<sub>mix</sub> (a) in the absence of RNA and in the presence of
(c) RNA containing the viral SARS-CoV-2 gene and (e) control noninfected RNA from the
Vero cells. The average of the hyperspectral data obtained from the
Au-ASO<sub>mix</sub> (b) in the absence of RNA and in the presence of (d) RNA
containing the viral SARS-CoV-2 gene and (f) control noninfected RNA from the Vero
cells. The overlay of hyperspectral data is represented in (g).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nn0c03822_0005" id="gr5" position="float"/></fig><p>In addition, it is also fundamentally important to identify the distribution and location
of each type of Au-ASOs in the hybrid cluster of Au-ASO<sub>mix</sub> when bound with its
target SARS-CoV-2 viral RNA. In order to receive this valuable information, the
hyperspectral data of each individual Au-ASOs (i.e., Au-ASO<sub>1M</sub>,
Au-ASO<sub>2L</sub>, Au-ASO<sub>3H</sub>, and Au-ASO<sub>4M</sub>) were recorded and
stored in the spectral library for further analysis. Using these data, an image
&#x0201c;map&#x0201d; was generated to identify the location of each individual Au-ASOs in
the hybrid cluster. <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref> illustrates the
mapping images of the Au-ASOs. It was observed that Au-ASO<sub>3H</sub> has the highest
distribution across the sample which was followed by Au-ASO<sub>4M</sub>,
Au-ASO<sub>1M</sub>, and Au-ASO<sub>2L</sub> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Figure S4</ext-link>) which might be a combinatorial effect of theoretical binding
disruption energies, theoretical target binding energies (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>), and experimental sensing capabilities of each of the ASOs (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>). <xref rid="fig6" ref-type="fig">Figure <xref rid="fig6" ref-type="fig">6</xref></xref>b&#x02013;f depicts a zoomed-in image of the hybrid cluster of gold
nanoparticles where the location of each of the Au-ASOs is represented using color code
(red, green, blue, and purple). Interestingly, the nanoparticles Au-ASO<sub>1M</sub> and
Au-ASO<sub>2L</sub> (red and green, respectively) were found to be localized in regions
close to each other which is primarily due to the proximity of their target position in
the <italic>N</italic> gene sequence of SARS-CoV-2, that is, the target position is
421&#x02013;440 for ASO1 and 443&#x02013;462 for ASO2 (<xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>), further assuring the hypothesis of the sensing mechanism.</p><fig id="fig6" position="float"><label>Figure 6</label><caption><p>Hyperspectral map image of the Au-ASO<sub>mix</sub> in the presence of the RNA of the
SARS-CoV-2 virus (a) EDFM-HSI original image, (b) overlay of the image
&#x0201c;map&#x0201d; on the EDFM-HSI image. (c&#x02013;g) Zoom-in image in the dotted
box of the AuNPs cluster showing the localization of (a) Au-ASO<sub>1M</sub> (red),
(b) Au-ASO<sub>2L</sub> (green), (c) Au-ASO<sub>3H</sub> (blue), (d)
Au-ASO<sub>4M</sub> (purple), and (f) overlay of the four Au-ASOs.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nn0c03822_0006" id="gr6" position="float"/></fig><p>The increase in sensitivity of Au-ASO<sub>mix</sub> nanoparticles was also monitored at a
definite concentration of RNA containing SARS-CoV-2 (1 ng/&#x003bc;L) with change in
incubation temperature and it was observed that the optimum sensitivity was achieved at 37
&#x000b0;C (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Figure S5</ext-link>). With this optimization, the change in absorbance of
Au-ASO<sub>mix</sub> at 660 nm was monitored with the increase in RNA concentrations
while incubating each sample for 5 min at a constant temperature of 37 &#x000b0;C. A constant
increase in absorbance with linear response was achieved which confirms the reliable and
stable response of the Au-ASO<sub>mix</sub> nanoparticle toward the SARS-CoV-2 RNA
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Figure S6</ext-link>). The limit of detection was found to be 0.18 ng/&#x003bc;L with a
tested dynamic range of 0.2&#x02013;3 ng/&#x003bc;L. The analytical performance of
Au-ASO<sub>mix</sub> nanoparticles toward the detection of viral SARS-CoV-2 RNA was
further validated by comparing the relative limit of detection of different ASO-stabilized
gold nanoparticles (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Figure S7</ext-link>). The relatively low limit of detection in the case of
Au-ASO<sub>mix</sub> nanoparticles can be corroborated with the analytical sensitivity
of differentially functionalized AuNPs (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Figure S1</ext-link>). A prominent change in color of the solution from violet to dark
blue was also observed after the addition of SARS-CoV-2 viral RNA load to the solution of
Au-ASO<sub>mix</sub> nanoparticles, and we tried to further improve its plasmonic signal
response. Accordingly, we tried to amplify the signal response from the
Au-ASO<sub>mix</sub> nanoparticle with further deposition of more gold on the initially
hybridized Au-ASO-RNA seeds.<sup><xref ref-type="bibr" rid="ref56">56</xref></sup> A solution containing
cetyltrimethylammonium bromide (CTAB) and ascorbic acid (AA) was then transferred to the
already hybridized Au-ASO<sub>mix</sub> nanoconjugate with SARS-CoV-2 RNA and mixed
properly. Chloroauric acid (HAuCl<sub>4</sub>) was then added to the mixture to initiate
the chemical deposition process which amplified the signal response almost to an average
of 75 times for the Au-ASO<sub>mix</sub> nanoparticle within an incubation time of 30 min
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Figure S8</ext-link>). The relative sensitivity of Au-ASO<sub>1M</sub> was also
compared with Au-ASO<sub>mix</sub> nanoparticles.</p></sec><sec id="sec2.4"><title>Selectivity of Au-ASO<sub>mix</sub> toward SARS-CoV-2</title><p>Another important parameter for any biosensor is the selectivity of the sensor toward its
target. In this regard, the selectivity of the current SARS-CoV-2 sensor was tested when
the Au-ASO<sub>mix</sub> nanoparticle was treated against the total RNA isolated from cell
lysate of Vero cells infected with MERS-CoV and the total RNA isolated from cell lysate of
noninfected Vero cells. An insignificant change in absorbance at 660 nm wavelength (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>a) was observed when the Au-ASO<sub>mix</sub>
nanoparticles were treated with these RNAs (1 ng/&#x003bc;L). Thus, both the RNAs extracted
from noninfected Vero cells and Vero cells infected with MERS-CoV acted as negative
controls for our experiments. Thus, the bioengineered ASO-capped gold nanoparticles,
Au-ASO<sub>mix</sub>, could potentially be used for the selective detection of
SARS-CoV-2. Further the selectivity of the Au-ASO<sub>mix</sub> nanoparticle was also
confirmed by the hyperspectral technique when the nanoparticles were treated with the RNA
isolated from the noninfected Vero cells as a negative control. <xref rid="fig5" ref-type="fig">Figure
<xref rid="fig5" ref-type="fig">5</xref></xref>e illustrates the EDFM-HSI of the Au-ASO<sub>mix</sub> after
the addition of the RNA isolated from the noninfected Vero cells. No obvious aggregates
were observed in the presence of this RNA, which supports our hypothesis about the
selectivity of the designed ASOs toward SARS-CoV-2. Insignificant change in hyperspectral
signature was also evident from <xref rid="fig5" ref-type="fig">Figures <xref rid="fig5" ref-type="fig">5</xref></xref>f and
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">S1c</ext-link>, further confirming the selectivity of the Au-ASO<sub>mix</sub>
nanoparticles toward SARS-CoV-2 viral RNA. Interestingly, a significant hyperspectral
shift (&#x0223c;100 nm) was found for the Au-ASO<sub>mix</sub> nanoparticles treated with
RNA containing the viral SARS-CoV-2 gene (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>g) confirming that the aggregation happens only in the presence of their target
RNA containing the viral <italic>N</italic> gene of SARS-CoV-2. Thus, the enhanced
dark-field microscopic images and the hyperspectral data confirmed the sensitivity and the
selectivity of the developed platform in identifying the presence of COVID-19 causative
virus, SARS-CoV-2, in the sample.</p><fig id="fig7" position="float"><label>Figure 7</label><caption><p>(a) Comparison of response of the Au-ASO<sub>mix</sub> nanoparticles toward the RNA
(1 ng/&#x003bc;L) isolated from noninfected Vero cells, Vero cells infected with
MERS-CoV, and Vero cells infected with SARS-CoV-2 virus. Relative change in absorbance
at 660 nm wavelength for the Au-ASO<sub>mix</sub> nanoparticle treated with SARS-CoV-2
RNA (1 ng/&#x003bc;L) followed by the addition of RNase H has been plotted in (b) when
the mixture was incubated at different temperatures for 5 min. The schematic
representation for the visual naked-eye detection of SARS-CoV-2 with the treatment of
RNase H at 65 &#x000b0;C for 5 min is shown in (c). The error bar indicates the average
results obtained from three such independent experiments performed in triplicate.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nn0c03822_0007" id="gr7" position="float"/></fig></sec><sec id="sec2.5"><title>Visual Naked-Eye Detection of SARS-CoV-2</title><p>Further we intended to receive a marked change in visual appearance of the test solution
in the presence of SARS-CoV-2 virus which could be easily detected even by a layman.
During the previous set of experiments, an increase in absorbance at 660 nm wavelength
with a redshift of &#x0223c;40 nm was observed with a difference in color from violet to
dark blue, but a marked change in visual appearance was desired to potentially be used for
the detection of SARS-CoV-2.</p><p>In this regard, we thought of a bioassay with the addition of thermostable RNase H to the
mixture containing Au-ASO<sub>mix</sub> and total RNA having the SARS-CoV-2 gene. It has
been envisaged that the thermostable RNase H will specifically recognize and cleave the
phosphodiester bonds of the SARS-CoV-2 RNA (N gene) strand hybridized with the
Au-ASO<sub>mix</sub> nanoconjugate while leaving the ASO strands intact. It has been
presumed that this treatment of RNase H may greatly influence the agglomeration propensity
among the gold nanoparticles that are already hybridized along the RNA strand which might
also fulfill our aim of achieving an immediate change in visual appearance of the
solution. To our expectation, no change in absorbance at 660 nm from the base absorbance
of Au-ASO<sub>mix</sub> nanoparticle was observed when the hybridized Au-ASO<sub>mix</sub>
nanoconjugate with SARS-CoV-2 RNA was treated with RNase H with an incubation of 5 min at
room temperature (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Figure S9</ext-link>). A further decrease in absorbance was observed when the mixture
was incubated at higher temperatures indicating the increased activity of RNase H at
elevated temperature levels (<xref rid="fig7" ref-type="fig">Figure <xref rid="fig7" ref-type="fig">7</xref></xref>b). A marked
change in visual appearance of the solution was achieved when the mixture was incubated at
an elevated temperature of 65 &#x000b0;C for 5 min (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Figure S10</ext-link>), which is schematically represented in <xref rid="fig7" ref-type="fig">Figure
<xref rid="fig7" ref-type="fig">7</xref></xref>c. This phenomenon may therefore be explained from the
activity of RNase H to selectively cleave the RNA strand from the RNA conjugate with
Au-ASO<sub>mix</sub> which leads to further agglomeration among the AuNPs those are
attached to the RNA strand followed by precipitation of AuNPs from the solution. The test
was also found to be selective to the presence of viral SARS-CoV-2 RNA load as the
treatment of RNase H to the sample containing Au-ASO<sub>mix</sub> and RNA from Vero cells
infected with MERS-CoV and caused no change in absorbance. Overall, this study reports the
naked-eye detection of COVID-19 causative virus, SARS-CoV-2 within a minimal time frame of
&#x0223c;10 min from the total RNA derived from the virus infected cells.</p><p>Thus, the present study describes the isolation of total RNA from a biosample infected
with the COVID-19 causative virus, SARS-CoV-2, and selective naked-eye detection of the
virus mediated by suitably designed antisense oligonucleotide capped gold nanoparticles.
The sensing mechanism initiates with the initial 5 min room temperature incubation of the
RNA samples having the viral load with a composite of ASO-capped AuNPs which is followed
by the treatment of RNase H at 65 &#x000b0;C for 5 min to generate a visual precipitate from
the solution. Furthermore, the present method describes the selective naked-eye
instrument-less detection of SARS-CoV-2 which can also be correlated with the
concentration of viral RNA present in the sample as the assay relies on the target-induced
aggregation and precipitation of the ASO-capped AuNPs. We have also compared the features
of our COVID-19 biosensor with the competing commercially available FDA approved or under
revision diagnostic approaches (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Tables S2 and S3</ext-link>) and peer-reviewed articles published on diagnostic
approaches (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Table S4</ext-link>) and proposed a new design of SARS-CoV-2 diagnostic test that can
selectively detect the presence of SARS-CoV-2 by naked-eye in a biospecimen without the
requirement of any sophisticated instrument. The reliability of many diagnostic tests fail
when they are tested either to a viral load at its early representation or to a viral gene
mutated during its current spread, but our sensor design attempts to compensate for these
drawbacks by directly targeting the <italic>N</italic> gene of SARS-CoV-2 simultaneously
at multiple positions of the gene.</p></sec></sec><sec id="sec3"><title>Conclusion</title><p>Briefly, we report herein the development of a colorimetric bioassay utilizing the
efficient targeting and binding ability of the antisense oligonucleotides specific for
<italic>N</italic>-gene of SARS-CoV-2 viral genome in conjugation with the anisotropic
plasmonic properties of gold nanoparticles. The methodology, described herein, further
utilizes an all-inclusive targeting approach mediated by four of the ASO sequences covering
two regions of the viral genome sequence, that is, <italic>N</italic>-gene of SARS-CoV-2, at
the same time. The gold nanoparticles when capped with the ASOs have been utilized for
diagnosing positive COVID-19 cases within 10 min from the total RNA isolated from the
infected biosamples. The thiol-modified ASO-capped AuNPs agglomerate selectively in the
presence of its target RNA sequence of SARS-CoV-2 and demonstrate a change in its SPR with a
redshift of &#x0223c;40 nm in their absorbance spectra. The agglomeration of ASO-capped gold
nanoparticles in the presence of SARS-CoV-2 RNA was studied by UV&#x02013;visible absorbance
spectroscopy, transmission electron microscopy, and hyperspectral microscopy. Further, the
addition of RNase H cleaves the RNA strand from the composite hybrid of RNA and
Au-ASO<sub>mix</sub>, leading to a visually detectable precipitate from the solution
mediated by the additional agglomeration among the AuNPs. The selectivity of this COVID-19
biosensor has also been tested against MERS-CoV viral RNA load where no distinct change in
absorbance was found with MERS-CoV RNA. Thus, the current study reports a reliable,
reproducible, selective, and visual naked-eye detection of COVID-19 causative virus,
SARS-CoV-2 which is devoid of the requirement of any sophisticated instrumental techniques.
In addition to this, the current methodology ensures its feasibility even with the mutated
<italic>N</italic> gene forms of the virus during its spread as the assay has been
designed to simultaneously target two separate regions of the gene. We also complied our
SARS-CoV-2 specific sensor with the ASSURED criteria, mentioned by WHO, where the biosensor
should have the following characteristics of (i) Affordable, (ii) Sensitive, (iii) Specific,
(iv) User-friendly, (v) Rapid and robust, (vi) sophisticated Equipment-free, and (vii)
Delivered to the end-users. Furthermore, the developed colorimetric bioassay could be
modified to target other regions of the viral genomic material, such as
<italic>S</italic>-gene (surface glycoprotein), <italic>E</italic>-gene (envelope protein)
and <italic>M</italic>-gene (membrane glycoprotein), for potential preclinical screening and
high sensitivity with minimal false positives.</p></sec><sec id="sec4"><title>Materials and Methods</title><sec id="sec4.1"><title>Materials</title><p>All of the chemicals were purchased from reputable commercial vendors and used without
any further purification steps. The custom designed and thiol-modified ASOs were procured
from GenScript and stored at &#x02212;20 &#x000b0;C. All the experiments were carried out at
constant room temperature of 25 &#x000b0;C unless otherwise specified. The Vero cells were
procured from ATCC (Vero E6; ATCC CRL-1586). The gamma-irradiated cell lysate and
supernatant from Vero E6 cells infected with SARS-CoV-2, isolate USA-WA1/2020, and Middle
East Respiratory Syndrome Coronavirus (MERS-CoV), EMC/2012 was obtained from BEI
Resources, NIAID, NIH. Thermostable RNase H was purchased from New England Biolabs.</p></sec><sec id="sec4.2"><title>Antisense Oligonucleotide Design</title><p>The target N-gene sequence of SARS-CoV-2, as mentioned in the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">Supporting Information</ext-link>, was supplied to a software for statistical folding
of nucleic acids, and studies of regulatory RNAs, Soligo,<sup><xref ref-type="bibr" rid="ref57">57</xref></sup> and the
ASOs were predicted maintaining the folding temperature as 37 &#x000b0;C and ionic conditions
of 1 M sodium chloride for a preferred length of ASO as 20 nucleotide bases. The filter
criteria were set as follows:<list list-type="simple"><list-item><label>1</label><p>40%
&#x02264; GC% &#x02264; 60%.</p></list-item><list-item><label>2</label><p>Elimination
of target sequences with GGGG.</p></list-item><list-item><label>3</label><p>Average
unpaired probability of the ASOs for target site nucleotides to be
&#x02265;0.5.</p></list-item><list-item><label>4</label><p>Considering the threshold
probability of above 0.5, all sites targeted to the peak in the accessibility
profile are ranked by their average unpaired probability (the higher the
better);</p></list-item><list-item><label>5</label><p>Among sites satisfying
criteria 1&#x02013;4, the top 20 ones with the highest average unpaired probability
will be considered. The average unpaired probability was also used in filter
criteria 3, 4, and 5 to reduce the number of reported sites in order to optimize the
disruption energy calculation in the web
servers.</p></list-item><list-item><label>6</label><p>Further, the binding energy of
the ASOs were also compared with the target sequence where the binding energy cutoff
for the selection of ASOs was kept at &#x02264;&#x02212;8
kcal/mol.</p></list-item></list></p></sec><sec id="sec4.3"><title>Synthesis of Citrate-Stabilized Gold Nanoparticles</title><p>A solution of 2.2 mM of sodium citrate was taken in Milli-Q water (150 mL) and refluxed
for 15 min under vigorous stirring. A solution of 1 mL of HAuCl<sub>4</sub> (25 mM) was
injected to the boiling solution of sodium citrate. The color of the solution changed over
a time period of 20 min. The resulting citrate-capped gold nanoparticles (AuNPs) were well
suspended in H<sub>2</sub>O.<sup><xref ref-type="bibr" rid="ref58">58</xref></sup></p></sec><sec id="sec4.4"><title>Functionalization of AuNPs with ASOs</title><p>Citrate-stabilized AuNPs were taken at &#x0223c;3 &#x000d7; 10<sup>10</sup> particles/mL
concentration as observed through zetaview software and treated with ASOs at three
different concentrations, that is, 0.5, 1, and 2 &#x003bc;M from a stock of 200 &#x003bc;M for
each of the four ASOs. The mixture was stirred at room temperature for 30 min, centrifuged
to remove any excess of uncapped ASO from the supernatant, and the pellet was then
resuspended in a similar volume of Milli-Q water. Accordingly, 12 different samples for
four of the ASOs at three different concentrations were prepared and nomenclatured as
Au-ASO<sub><italic>x</italic>L</sub>, Au-ASO<sub><italic>x</italic>M</sub>, and
Au-ASO<sub><italic>x</italic>H</sub> where <italic>x</italic> defines the number of
ASO as 1, 2, 3, or 4 and L, M and H are representative of low, medium and high
concentrations of ASOs respectively. The nanoparticles were kept at 4 &#x000b0;C for future
use.</p></sec><sec id="sec4.5"><title>Cell Culture</title><p>The Cercopithecus aethiops kidney epithelial cells (Vero E6) were procured from ATCC
(CRL-1586) and cultured at standard conditions in Eagle&#x02019;s Minimum Essential Medium
with the supplement of 10% fetal bovine serum at 37 &#x000b0;C. The cells were trypsinized
with 0.25% (w/v) Trypsin- 0.53 mM EDTA solution while maintaining the culture.</p></sec><sec id="sec4.6"><title>Isolation of RNA</title><p>Severe acute respiratory syndrome-related coronavirus (SARS-CoV-2), isolate USA-WA1/2020
was isolated from an oropharyngeal swab of a patient with a respiratory illness. The
patient had returned from travel to the affected region of China and had developed
clinical disease (COVID-19) in January 2020 in Washington, U.S.A. The sample, NR-52287, as
obtained from BEI Resources, NIAID, NIH, consists of a crude preparation of cell lysate
and supernatant from Cercopithecus aethiops kidney epithelial cells (Vero E6; ATCC
CRL-1586) infected with severe acute respiratory syndrome-related coronavirus 2
(SARS-CoV-2), isolate USA-WA1/2020 that was gamma-irradiated (5 &#x000d7; 10<sup>6</sup>
RADs) on dry ice. The sample, NR-50549, as obtained from BEI Resources, NIAID, NIH,
consists of a gamma-irradiated cell lysate and supernatant from Vero cells infected with
MERS-CoV, EMC/2012. This sample was isolated from a man with pneumonia in Saudi
Arabia.</p><p>The Vero cells with or without the viral transfection were lysed directly in a culture
dish by adding 1 mL of TRIzol reagent and aspirated carefully. The total RNA was then
extracted and purified for the viral RNA from the cellular lysate with a commercially
available kit. The concentration of purified RNA, isolated from the SARS-CoV-2 infected
Vero cells, was found to be 35.9 ng/&#x003bc;L, while the concentration of the purified RNA,
isolated from the noninfected Vero cells, was 92.6 ng/&#x003bc;L.</p></sec><sec id="sec4.7"><title>Sample Standardization Protocol</title><p>The as-synthesized nanoparticles were taken out from the refrigerator, sonicated for 5
min in a bath sonicator (Branson 2800) at room temperature, and vortexed for 2 min prior
use. To determine the sensing capability of the individually ASO-capped gold
nanoparticles, the as-synthesized solution containing the AuNPs were treated with RNA
samples having the concentration of 1 ng/&#x003bc;L. For the preparation of each 100
&#x003bc;L of Au-ASO<sub>mix</sub>, 25 &#x003bc;L of each individual Au-ASO<sub>1M</sub>,
Au-ASO<sub>2L</sub>, Au-ASO<sub>3H</sub>, and Au-ASO<sub>4M</sub> nanoparticles were
mixed and vortexed thoroughly. The sensing and targeting capability of the
Au-ASO<sub>mix</sub> was also validated at a RNA concentration of 1 ng/&#x003bc;L.</p></sec><sec id="sec4.8"><title>Protocol for Signal Amplification</title><p>The signal amplification was investigated following a literature reported
protocol.<sup><xref ref-type="bibr" rid="ref54">54</xref></sup> Briefly, 100 &#x003bc;L solution of Au-ASO<sub>mix</sub>
was first treated with RNA containing SARS-CoV-2 at a concentration of 1 ng/&#x003bc;L. This
solution was then incubated with CTAB, <sc>l</sc>-ascorbic acid, and HAuCl<sub>4</sub> at
a concentration of 0.1 M, 0.45 mM, and 0.225 mM, respectively, and monitored over several
time points.</p></sec><sec id="sec4.9"><title>Protocol for RNase H Treatment</title><p>For each 100 &#x003bc;L of reaction, 10 &#x003bc;L of RNase H reaction buffer (1X) was used
along with 1 &#x003bc;L of thermostable RNase H and incubated for a required time at a
definite temperature. The 100 &#x003bc;L solution of Au-ASO<sub>mix</sub> nanoparticle was
first treated with RNA samples having 1 ng/&#x003bc;L concentration and then incubated with
RNase H reaction buffer (1X) and thermostable RNase H for required time points and
temperature.</p></sec><sec id="sec4.10"><title>Absorbance Spectra</title><p>The absorbance spectra were initially acquired on a VWR UV&#x02013;vis spectrophotometer,
while the assays with 96-well plates were monitored on Biotek Synergy Neo2Microplate
Reader both for end point, kinetic, and spectral analyses.</p></sec><sec id="sec4.11"><title>Measurement of Hydrodynamic Diameter</title><p>The hydrodynamic diameters of the individually ASO-capped gold nanoparticles and the
composite nanoparticles (Au-ASO<sub>mix</sub>) were monitored on a particle tracking
analyzer (Zetaview Particle Metrix). The hydrodynamic diameters of Au-ASO<sub>mix</sub>
before and after the addition of RNA at a concentration of 1 ng/&#x003bc;L were also
observed in a similar fashion. The as-synthesized nanoparticles were diluted 50 times and
1 mL of such diluted samples were injected into the machine for the measurements. The
chamber of the machine was properly cleaned prior to each measurement.</p></sec><sec id="sec4.12"><title>Transmission Electron Microscopy</title><p>The as-synthesized nanoparticles, Au-ASO<sub>mix</sub> before and after the addition of
RNA at a concentration of 1 ng/&#x003bc;L, were investigated under the transmission electron
microscope (FEI tecnai T12). The tungsten filament was used as the electron optics, and
the voltage was kept constant at 80 kV. A 20 &#x003bc;L sample droplet was spotted onto a
carbon-coated copper grid (400 mesh) and allowed to stay there for about 10 min before
being removed.</p></sec><sec id="sec4.13"><title>Hyperspectral Analyses</title><p>The as-synthesized nanoparticles, Au-ASO<sub>mix</sub> before and after the addition of
RNA at a concentration of 1 ng/&#x003bc;L, were also monitored under the dark-field optical
microscope (CytoViva), and their hyperspectra were acquired by the hyperspectral recorder
from CytoViva. The hyperspectra were compared for the Au-ASO<sub>mix</sub> nanoparticles
when treated with the RNA isolated from the Vero cells with or without transfected with
SARS-CoV-2 separately. A 20 &#x003bc;L sample droplet was spotted onto a glass slide and a
coverslip was placed on top of it.</p></sec></sec></body><back><notes id="notes1" notes-type="si"><title>Supporting Information Available</title><p>The following files are available online free of charge: N-gene sequence, figure
S1&#x02013;S10, movie S1&#x02013;S3, table S1&#x02013;S4 and supporting references. The
Supporting Information is available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acsnano.0c03822?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c03822</ext-link>.<list id="silist" list-type="simple"><list-item><p>(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_001.pdf">PDF</ext-link>)</p></list-item><list-item><p>Screenshots of Au-ASO<sub>mix</sub>
nanoparticles as observed through zetaview (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_002.mp4">MP4</ext-link>)</p></list-item><list-item><p>Screenshots of Au-ASO<sub>mix</sub>
nanoparticles as observed through zetaview after the addition of total RNA (1
ng/&#x003bc;L) isolated from the Vero cells infected with SARS-CoV-2 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_003.mp4">MP4</ext-link>)</p></list-item><list-item><p>The movement of agglomerated
Au-ASO<sub>mix</sub> nanoparticles as a string in presence of SARS-CoV-2 RNA
(<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsnano.0c03822/suppl_file/nn0c03822_si_004.mp4">MP4</ext-link>)</p></list-item></list></p></notes><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="sifile1"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nn0c03822_si_001.pdf"><caption><p>nn0c03822_si_001.pdf</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile2"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nn0c03822_si_002.mp4"><caption><p>nn0c03822_si_002.mp4</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile3"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nn0c03822_si_003.mp4"><caption><p>nn0c03822_si_003.mp4</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="sifile4"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="nn0c03822_si_004.mp4"><caption><p>nn0c03822_si_004.mp4</p></caption></media></supplementary-material></sec><notes notes-type="" id="notes2"><title>Author Contributions</title><p><sup>#</sup> P.M. and M.A. contributed equally to this work.</p></notes><notes notes-type="" id="notes3"><title>Author Contributions</title><p>The manuscript was written through contributions of all authors. All authors have given
approval to the final version of the manuscript.</p></notes><notes notes-type="COI-statement" id="NOTES-d7e1391-autogenerated"><p>The authors declare the following competing financial interest(s): Prof Pan is the founder
or co-founder of three University based start ups. None of these entities however, supported
this work.</p></notes><ack><title>Acknowledgments</title><p>Authors gratefully acknowledge the receipt of funding from University of Maryland Baltimore
and University of Maryland Baltimore County. The following reagents were deposited by the
Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH:
(i) SARS-Related Coronavirus 2, Isolate USA-WA1/2020, Gamma-Irradiated, NR-52287 and (ii)
Middle East Respiratory Syndrome Coronavirus (MERS CoV), EMC/2012, Irradiated Infected Cell
Lysate, NR-50549.</p></ack><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal" id="cit1"><name><surname>Huang</surname><given-names>C.</given-names></name>; <name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Ren</surname><given-names>L.</given-names></name>; <name><surname>Zhao</surname><given-names>J.</given-names></name>; <name><surname>Hu</surname><given-names>Y.</given-names></name>; <name><surname>Zhang</surname><given-names>L.</given-names></name>; <name><surname>Fan</surname><given-names>G.</given-names></name>; <name><surname>Xu</surname><given-names>J.</given-names></name>; <name><surname>Gu</surname><given-names>X.</given-names></name>; <name><surname>Cheng</surname><given-names>Z.</given-names></name>; <name><surname>Yu</surname><given-names>T.</given-names></name>; <name><surname>Xia</surname><given-names>J.</given-names></name>; <name><surname>Wei</surname><given-names>Y.</given-names></name>; <name><surname>Wu</surname><given-names>W.</given-names></name>; <name><surname>Xie</surname><given-names>X.</given-names></name>; <name><surname>Yin</surname><given-names>W.</given-names></name>; <name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Liu</surname><given-names>M.</given-names></name>; <name><surname>Xiao</surname><given-names>Y.</given-names></name>; <name><surname>Gao</surname><given-names>H.</given-names></name>; <name><surname>Guo</surname><given-names>L.</given-names></name>; <name><surname>Xie</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>G.</given-names></name>; <name><surname>Jiang</surname><given-names>R.</given-names></name>; <name><surname>Gao</surname><given-names>Z.</given-names></name>; <name><surname>Jin</surname><given-names>Q.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Cao</surname><given-names>B.</given-names></name>
<article-title>Clinical Features of Patients Infected with 2019 Novel Coronavirus in
Wuhan, China</article-title>. <source>Lancet</source>
<year>2020</year>, <volume>395</volume>, <fpage>497</fpage>&#x02013;<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30183-5</pub-id>.<pub-id pub-id-type="pmid">31986264</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal" id="cit2"><name><surname>Velavan</surname><given-names>T. P.</given-names></name>; <name><surname>Meyer</surname><given-names>C. G.</given-names></name>
<article-title>The Covid-19 Epidemic</article-title>. <source>Trop. Med. Int. Health</source>
<year>2020</year>, <volume>25</volume>, <fpage>278</fpage>&#x02013;<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1111/tmi.13383</pub-id>.<pub-id pub-id-type="pmid">32052514</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal" id="cit3"><name><surname>Phan</surname><given-names>T.</given-names></name>
<article-title>Genetic Diversity and Evolution of Sars-Cov-2</article-title>. <source>Infect., Genet. Evol.</source>
<year>2020</year>, <volume>81</volume>, <fpage>104260</fpage><pub-id pub-id-type="doi">10.1016/j.meegid.2020.104260</pub-id>.<pub-id pub-id-type="pmid">32092483</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal" id="cit4"><name><surname>Sun</surname><given-names>Fu.</given-names></name>; <name><surname>Ganguli</surname><given-names>A.</given-names></name>; <name><surname>Nguyen</surname><given-names>J.</given-names></name>; <name><surname>Brisbin</surname><given-names>R.</given-names></name>; <name><surname>Shanmugam</surname><given-names>K.</given-names></name>; <name><surname>Hirschberg</surname><given-names>D. L.</given-names></name>; <name><surname>Wheeler</surname><given-names>M. B.</given-names></name>; <name><surname>Bashir</surname><given-names>R.</given-names></name>; <name><surname>Nash</surname><given-names>D. M.</given-names></name>; <name><surname>Cunningham</surname><given-names>B. T.</given-names></name>
<article-title>Smartphone-Based Multiplex 30-minute Nucleic Acid Test of Live Virus from
Nasal Swab Extract</article-title>. <source>Lab Chip</source>
<year>2020</year>, <volume>20</volume>, <fpage>1621</fpage>&#x02013;<lpage>1627</lpage>. <pub-id pub-id-type="doi">10.1039/D0LC00304B</pub-id>.<pub-id pub-id-type="pmid">32334422</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal" id="cit5"><name><surname>Wu</surname><given-names>F.</given-names></name>; <name><surname>Zhao</surname><given-names>S.</given-names></name>; <name><surname>Yu</surname><given-names>B.</given-names></name>; <name><surname>Chen</surname><given-names>Y. M.</given-names></name>; <name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Song</surname><given-names>Z. G.</given-names></name>; <name><surname>Hu</surname><given-names>Y.</given-names></name>; <name><surname>Tao</surname><given-names>Z. W.</given-names></name>; <name><surname>Tian</surname><given-names>J. H.</given-names></name>; <name><surname>Pei</surname><given-names>Y. Y.</given-names></name>; <name><surname>Yuan</surname><given-names>M. L.</given-names></name>; <name><surname>Zhang</surname><given-names>Y. L.</given-names></name>; <name><surname>Dai</surname><given-names>F. H.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Wang</surname><given-names>Q. M.</given-names></name>; <name><surname>Zheng</surname><given-names>J. J.</given-names></name>; <name><surname>Xu</surname><given-names>L.</given-names></name>; <name><surname>Holmes</surname><given-names>E. C.</given-names></name>; <name><surname>Zhang</surname><given-names>Y. Z.</given-names></name>
<article-title>A New Coronavirus Associated with Human Respiratory Disease in
China</article-title>. <source>Nature</source>
<year>2020</year>, <volume>579</volume>, <fpage>265</fpage>&#x02013;<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2008-3</pub-id>.<pub-id pub-id-type="pmid">32015508</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal" id="cit6"><article-title>The Species Severe Acute Respiratory Syndrome-Related Coronavirus:
Classifying 2019-nCoV and Naming It SARS-CoV-2</article-title>. <source>Nat. Microbiol.</source>
<year>2020</year>, <volume>5</volume>, <fpage>536</fpage>&#x02013;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-020-0695-z</pub-id>.<pub-id pub-id-type="pmid">32123347</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal" id="cit7"><name><surname>de Wit</surname><given-names>E.</given-names></name>; <name><surname>van Doremalen</surname><given-names>N.</given-names></name>; <name><surname>Falzarano</surname><given-names>D.</given-names></name>; <name><surname>Munster</surname><given-names>V. J.</given-names></name>
<article-title>SARS and MERS: Recent Insights into Emerging Coronaviruses</article-title>. <source>Nat. Rev. Microbiol.</source>
<year>2016</year>, <volume>14</volume>, <fpage>523</fpage>&#x02013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro.2016.81</pub-id>.<pub-id pub-id-type="pmid">27344959</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal" id="cit8"><name><surname>Lu</surname><given-names>R.</given-names></name>; <name><surname>Zhao</surname><given-names>X.</given-names></name>; <name><surname>Li</surname><given-names>J.</given-names></name>; <name><surname>Niu</surname><given-names>P.</given-names></name>; <name><surname>Yang</surname><given-names>B.</given-names></name>; <name><surname>Wu</surname><given-names>H.</given-names></name>; <name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Song</surname><given-names>H.</given-names></name>; <name><surname>Huang</surname><given-names>B.</given-names></name>; <name><surname>Zhu</surname><given-names>N.</given-names></name>; <name><surname>Bi</surname><given-names>Y.</given-names></name>; <name><surname>Ma</surname><given-names>X.</given-names></name>; <name><surname>Zhan</surname><given-names>F.</given-names></name>; <name><surname>Wang</surname><given-names>L.</given-names></name>; <name><surname>Hu</surname><given-names>T.</given-names></name>; <name><surname>Zhou</surname><given-names>H.</given-names></name>; <name><surname>Hu</surname><given-names>Z.</given-names></name>; <name><surname>Zhou</surname><given-names>W.</given-names></name>; <name><surname>Zhao</surname><given-names>L.</given-names></name>; <name><surname>Chen</surname><given-names>J.</given-names></name>; et al. <article-title>Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus:
Implications for Virus Origins and Receptor Binding</article-title>. <source>Lancet</source>
<year>2020</year>, <volume>395</volume>, <fpage>565</fpage>&#x02013;<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30251-8</pub-id>.<pub-id pub-id-type="pmid">32007145</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal" id="cit9"><name><surname>Li</surname><given-names>Q.</given-names></name>; <name><surname>Guan</surname><given-names>X.</given-names></name>; <name><surname>Wu</surname><given-names>P.</given-names></name>; <name><surname>Wang</surname><given-names>X.</given-names></name>; <name><surname>Zhou</surname><given-names>L.</given-names></name>; <name><surname>Tong</surname><given-names>Y.</given-names></name>; <name><surname>Ren</surname><given-names>R.</given-names></name>; <name><surname>Leung</surname><given-names>K. S. M.</given-names></name>; <name><surname>Lau</surname><given-names>E. H. Y.</given-names></name>; <name><surname>Wong</surname><given-names>J. Y.</given-names></name>; <name><surname>Xing</surname><given-names>X.</given-names></name>; <name><surname>Xiang</surname><given-names>N.</given-names></name>; <name><surname>Wu</surname><given-names>Y.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Chen</surname><given-names>Q.</given-names></name>; <name><surname>Li</surname><given-names>D.</given-names></name>; <name><surname>Liu</surname><given-names>T.</given-names></name>; <name><surname>Zhao</surname><given-names>J.</given-names></name>; <name><surname>Liu</surname><given-names>M.</given-names></name>; <name><surname>Tu</surname><given-names>W.</given-names></name>; et al. <article-title>Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected
Pneumonia</article-title>. <source>N. Engl. J. Med.</source>
<year>2020</year>, <volume>382</volume>, <fpage>1199</fpage>&#x02013;<lpage>1207</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa2001316</pub-id>.<pub-id pub-id-type="pmid">31995857</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal" id="cit10"><name><surname>Guan</surname><given-names>W.</given-names></name>; <name><surname>Ni</surname><given-names>Z.</given-names></name>; <name><surname>Hu</surname><given-names>Y.</given-names></name>; <name><surname>Liang</surname><given-names>W.</given-names></name>; <name><surname>Ou</surname><given-names>C.</given-names></name>; <name><surname>He</surname><given-names>J.</given-names></name>; <name><surname>Liu</surname><given-names>L.</given-names></name>; <name><surname>Shan</surname><given-names>H.</given-names></name>; <name><surname>Lei</surname><given-names>C.</given-names></name>; <name><surname>Hui</surname><given-names>D. S. C.</given-names></name>; <name><surname>Du</surname><given-names>B.</given-names></name>; <name><surname>Li</surname><given-names>L.</given-names></name>; <name><surname>Zeng</surname><given-names>G.</given-names></name>; <name><surname>Yuen</surname><given-names>K.-Y.</given-names></name>; <name><surname>Chen</surname><given-names>R.</given-names></name>; <name><surname>Tang</surname><given-names>C.</given-names></name>; <name><surname>Wang</surname><given-names>T.</given-names></name>; <name><surname>Chen</surname><given-names>P.</given-names></name>; <name><surname>Xiang</surname><given-names>J.</given-names></name>; <name><surname>Li</surname><given-names>S.</given-names></name>
<article-title>Clinical Characteristics of 2019 Novel Coronavirus Infection in
China</article-title>. <source>N. Engl. J. Med.</source>
<year>2020</year>, <volume>382</volume>, <fpage>1708</fpage><pub-id pub-id-type="doi">10.1056/NEJMoa2002032</pub-id>.<pub-id pub-id-type="pmid">32109013</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal" id="cit11"><person-group person-group-type="allauthors"><name><surname>Yang</surname><given-names>Y.</given-names></name>;
<name><surname>Lu</surname><given-names>Q.</given-names></name>;
<name><surname>Liu</surname><given-names>M.</given-names></name>;
<name><surname>Wang</surname><given-names>Y.</given-names></name>;
<name><surname>Zhang</surname><given-names>A.</given-names></name>;
<name><surname>Jalali</surname><given-names>N.</given-names></name>;
<name><surname>Dean</surname><given-names>N.</given-names></name>;
<name><surname>Longini</surname><given-names>I.</given-names></name>;
<name><surname>Halloran</surname><given-names>M. E.</given-names></name>;
<name><surname>Xu</surname><given-names>B.</given-names></name>;
<name><surname>Zhang</surname><given-names>X.</given-names></name>;
<name><surname>Wang</surname><given-names>L.</given-names></name>;
<name><surname>Liu</surname><given-names>W.</given-names></name>;
<name><surname>Fang</surname><given-names>L.</given-names></name></person-group><article-title>Epidemiological and Clinical Features of the 2019 Novel Coronavirus
Outbreak in China</article-title>. <source>medRxiv</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.02.10.20021675</pub-id> (accessed May 4, 2020).</mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal" id="cit12"><name><surname>Huang</surname><given-names>H.</given-names></name>; <name><surname>Fan</surname><given-names>C.</given-names></name>; <name><surname>Li</surname><given-names>M.</given-names></name>; <name><surname>Nie</surname><given-names>H.-L.</given-names></name>; <name><surname>Wang</surname><given-names>F.-B.</given-names></name>; <name><surname>Wang</surname><given-names>H.</given-names></name>; <name><surname>Wang</surname><given-names>R.</given-names></name>; <name><surname>Xia</surname><given-names>J.</given-names></name>; <name><surname>Zheng</surname><given-names>X.</given-names></name>; <name><surname>Zuo</surname><given-names>X.</given-names></name>; <name><surname>Huang</surname><given-names>J.</given-names></name>
<article-title>COVID-19: A Call for Physical Scientists and Engineers</article-title>. <source>ACS Nano</source>
<year>2020</year>, <volume>14</volume>, <fpage>3747</fpage>&#x02013;<lpage>3754</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.0c02618</pub-id>.<pub-id pub-id-type="pmid">32267678</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="book" id="cit13"><person-group person-group-type="allauthors"><name><surname>Ferguson</surname><given-names>N.</given-names></name>;
<name><surname>Laydon</surname><given-names>D.</given-names></name>;
<name><surname>Nedjati-Gilan</surname><given-names>i G.</given-names></name>;
<name><surname>Imai</surname><given-names>N.</given-names></name>;
<name><surname>Ainslie</surname><given-names>K.</given-names></name>;
<name><surname>Baguelin</surname><given-names>M.</given-names></name>;
<name><surname>Bhatia</surname><given-names>S.</given-names></name>;
<name><surname>Boonyasiri</surname><given-names>A.</given-names></name>;
<name><surname>Cucunub&#x000e1;</surname><given-names>P. Z.</given-names></name>;
<name><surname>Cuomo-Dannenburg</surname><given-names>G.</given-names></name>;
<name><surname>Dighe</surname><given-names>A.</given-names></name>;
<name><surname>Dorigatti</surname><given-names>I.</given-names></name>;
<name><surname>Fu</surname><given-names>H.</given-names></name>;
<name><surname>Gaythorpe</surname><given-names>K.</given-names></name>;
<name><surname>Green</surname><given-names>W.</given-names></name>;
<name><surname>Hamlet</surname><given-names>A.</given-names></name>;
<name><surname>Hinsley</surname><given-names>W.</given-names></name>;
<name><surname>Okell</surname><given-names>L.</given-names></name>; <name><surname>Van
Elsland</surname><given-names>S.</given-names></name>;
<name><surname>Thompson</surname><given-names>H.</given-names></name></person-group><etal/><source>Report 9: Impact of Non-Pharmaceutical Interventions (NPIs) to Reduce COVID-19
Mortality and Healthcare Demand</source>; <publisher-name>Imperial College
London</publisher-name>: <publisher-loc>London</publisher-loc>, <year>2020</year>; pp
<fpage>1</fpage>&#x02013;<lpage>20</lpage>.</mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal" id="cit14"><name><surname>Prem</surname><given-names>K.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Russell</surname><given-names>T. W.</given-names></name>; <name><surname>Kucharski</surname><given-names>A. J.</given-names></name>; <name><surname>Eggo</surname><given-names>R. M.</given-names></name>; <name><surname>Davies</surname><given-names>N.</given-names></name>; <name><surname>Flasche</surname><given-names>S.</given-names></name>; <name><surname>Clifford</surname><given-names>S.</given-names></name>; <name><surname>Pearson</surname><given-names>C. A. B.</given-names></name>; <name><surname>Munday</surname><given-names>J. D.</given-names></name>; <name><surname>Abbott</surname><given-names>S.</given-names></name>; <name><surname>Gibbs</surname><given-names>H.</given-names></name>; <name><surname>Rosello</surname><given-names>A.</given-names></name>; <name><surname>Quilty</surname><given-names>B. J.</given-names></name>; <name><surname>Jombart</surname><given-names>T.</given-names></name>; <name><surname>Sun</surname><given-names>F.</given-names></name>; <name><surname>Diamond</surname><given-names>C.</given-names></name>; <name><surname>Gimma</surname><given-names>A.</given-names></name>; <name><surname>van Zandvoort</surname><given-names>K.</given-names></name>; <name><surname>Funk</surname><given-names>S.</given-names></name>; <name><surname>Jarvis</surname><given-names>C. I.</given-names></name>; <name><surname>Edmunds</surname><given-names>W. J.</given-names></name>; <name><surname>Bosse</surname><given-names>N. I.</given-names></name>; <name><surname>Hellewell</surname><given-names>J.</given-names></name>; <name><surname>Jit</surname><given-names>M.</given-names></name>; <name><surname>Klepac</surname><given-names>P.</given-names></name>
<article-title>The Effect of Control Strategies to Reduce Social Mixing on Outcomes of the
COVID-19 Epidemic in Wuhan, China: A Modelling Study</article-title>. <source>Lancet Public Health</source>
<year>2020</year>, <volume>5</volume>, <fpage>E261</fpage>&#x02013;<lpage>E270</lpage>. <pub-id pub-id-type="doi">10.1016/S2468-2667(20)30073-6</pub-id>.<pub-id pub-id-type="pmid">32220655</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="weblink" id="cit15"><person-group person-group-type="allauthors"><name><surname>Normalie</surname><given-names>D.</given-names></name></person-group><article-title>Coronavirus Cases Have Dropped Sharply in South Korea. What&#x02019;s the
Secret to Its Success?</article-title><uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.sciencemag.org/news/2020/03/coronavirus-cases-have-dropped-sharply-south-korea-whats-secret-its-success">https://www.sciencemag.org/news/2020/03/coronavirus-cases-have-dropped-sharply-south-korea-whats-secret-its-success</uri>.
March 17, <year>2020</year> (accessed May 4, 2020).</mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal" id="cit16"><name><surname>Colbourn</surname><given-names>T.</given-names></name>
<article-title>COVID-19: Extending or Relaxing Distancing Control Measures</article-title>. <source>Lancet Public Health</source>
<year>2020</year>, <volume>5</volume>, <fpage>E236</fpage>&#x02013;<lpage>E237</lpage>. <pub-id pub-id-type="doi">10.1016/S2468-2667(20)30072-4</pub-id>.<pub-id pub-id-type="pmid">32220654</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal" id="cit17"><name><surname>Rahimi</surname><given-names>F.</given-names></name>; <name><surname>Talebi Bezmin Abadi</surname><given-names>A.</given-names></name>
<article-title>Practical Strategies against the Novel Coronavirus and COVID-19 &#x02014;
The Imminent Global Threat</article-title>. <source>Arch. Med. Res.</source>
<year>2020</year>, <volume>51</volume>, <fpage>280</fpage><pub-id pub-id-type="doi">10.1016/j.arcmed.2020.03.005</pub-id>.<pub-id pub-id-type="pmid">32229157</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal" id="cit18"><name><surname>Rodriguez-Morales</surname><given-names>A. J.</given-names></name>; <name><surname>MacGregor</surname><given-names>K.</given-names></name>; <name><surname>Kanagarajah</surname><given-names>S.</given-names></name>; <name><surname>Patel</surname><given-names>D.</given-names></name>; <name><surname>Schlagenhauf</surname><given-names>P.</given-names></name>
<article-title>Going Global - Travel and the 2019 Novel Coronavirus</article-title>. <source>Travel Med. Infect. Dis.</source>
<year>2020</year>, <volume>33</volume>, <fpage>101578</fpage><pub-id pub-id-type="doi">10.1016/j.tmaid.2020.101578</pub-id>.<pub-id pub-id-type="pmid">32044389</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal" id="cit19"><name><surname>Dhama</surname><given-names>K.</given-names></name>; <name><surname>Sharun</surname><given-names>K.</given-names></name>; <name><surname>Tiwari</surname><given-names>R.</given-names></name>; <name><surname>Sircar</surname><given-names>S.</given-names></name>; <name><surname>Bhat</surname><given-names>S.</given-names></name>; <name><surname>Malik</surname><given-names>Y. S.</given-names></name>; <name><surname>Singh</surname><given-names>K. P.</given-names></name>; <name><surname>Chaicumpa</surname><given-names>W.</given-names></name>; <name><surname>Bonilla-Aldana</surname><given-names>D. K.</given-names></name>; <name><surname>Rodriguez-Morales</surname><given-names>A. J.</given-names></name>
<article-title>Coronavirus Disease 2019 &#x02013; COVID-19</article-title>. <source>Preprints</source>
<year>2020</year>, <fpage>2020030001</fpage><comment>(accessed May 4, 2020)</comment><pub-id pub-id-type="doi">10.20944/preprints202003.0001.v1</pub-id>.</mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal" id="cit20"><name><surname>Ai</surname><given-names>T.</given-names></name>; <name><surname>Yang</surname><given-names>Z.</given-names></name>; <name><surname>Hou</surname><given-names>H.</given-names></name>; <name><surname>Zhan</surname><given-names>C.</given-names></name>; <name><surname>Chen</surname><given-names>C.</given-names></name>; <name><surname>Lv</surname><given-names>W.</given-names></name>; <name><surname>Tao</surname><given-names>Q.</given-names></name>; <name><surname>Sun</surname><given-names>Z.</given-names></name>; <name><surname>Xia</surname><given-names>L.</given-names></name>
<article-title>Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019
(Covid-19) in China: A Report of 1014 Cases</article-title>. <source>Radiology</source>
<year>2020</year>, <fpage>200642</fpage><pub-id pub-id-type="doi">10.1148/radiol.2020200642</pub-id>.<pub-id pub-id-type="pmid">32101510</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal" id="cit21"><person-group person-group-type="allauthors"><name><surname>Kim</surname><given-names>H.</given-names></name></person-group><article-title>Outbreak of Novel Coronavirus (Covid-19): What Is the Role of
Radiologists?</article-title><source>Eur. Radiology</source><year>2020</year><pub-id pub-id-type="doi">10.1007/s00330-020-06748-2</pub-id>, (accessed May 4,
2020).</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal" id="cit22"><name><surname>Wang</surname><given-names>W.</given-names></name>; <name><surname>Xu</surname><given-names>Y.</given-names></name>; <name><surname>Gao</surname><given-names>R.</given-names></name>; <name><surname>Lu</surname><given-names>R.</given-names></name>; <name><surname>Han</surname><given-names>K.</given-names></name>; <name><surname>Wu</surname><given-names>G.</given-names></name>; <name><surname>Tan</surname><given-names>W.</given-names></name>
<article-title>Detection of SARS-CoV-2 in Different Types of Clinical
Specimens</article-title>. <source>JAMA</source>
<year>2020</year>, <volume>323</volume>, <fpage>1843</fpage>&#x02013;<lpage>1844</lpage>. <pub-id pub-id-type="doi">10.1001/jama.2020.3786</pub-id>.</mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal" id="cit23"><name><surname>Carter</surname><given-names>L. J.</given-names></name>; <name><surname>Garner</surname><given-names>L. V.</given-names></name>; <name><surname>Smoot</surname><given-names>J. W.</given-names></name>; <name><surname>Li</surname><given-names>Y.</given-names></name>; <name><surname>Zhou</surname><given-names>Q.</given-names></name>; <name><surname>Saveson</surname><given-names>C. J.</given-names></name>; <name><surname>Sasso</surname><given-names>J. S.</given-names></name>; <name><surname>Gregg</surname><given-names>A. C.</given-names></name>; <name><surname>Soares</surname><given-names>D. J.</given-names></name>; <name><surname>Beskid</surname><given-names>T. R.</given-names></name>; <name><surname>Jervey</surname><given-names>S. R.</given-names></name>; <name><surname>Liu</surname><given-names>C.</given-names></name>
<article-title>Assay Techniques and Test Development for COVID-19
Diagnosis</article-title>. <source>ACS Cent. Sci.</source>
<year>2020</year>, <volume>6</volume>, <fpage>591</fpage>&#x02013;<lpage>605</lpage>. <pub-id pub-id-type="doi">10.1021/acscentsci.0c00501</pub-id>.<pub-id pub-id-type="pmid">32382657</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal" id="cit24"><person-group person-group-type="allauthors"><name><surname>Yu</surname><given-names>L.</given-names></name>;
<name><surname>Wu</surname><given-names>S.</given-names></name>;
<name><surname>Hao</surname><given-names>X.</given-names></name>;
<name><surname>Dong</surname><given-names>X.</given-names></name>;
<name><surname>Mao</surname><given-names>L.</given-names></name>;
<name><surname>Pelechano</surname><given-names>V.</given-names></name>;
<name><surname>Chen</surname><given-names>W.-H.</given-names></name>;
<name><surname>Yin</surname><given-names>X.</given-names></name></person-group><article-title>Rapid Detection of COVID-19 Coronavirus Using a Reverse Transcriptional
Loop-Mediated Isothermal Amplification (RT-LAMP) Diagnostic Platform</article-title>,
<source>Clin. Chem.</source><year>2020</year>; <fpage>hvaa102</fpage><pub-id pub-id-type="doi">10.1093/clinchem/hvaa102</pub-id>.<pub-id pub-id-type="pmid">32315390</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="weblink" id="cit25"><person-group person-group-type="allauthors"><collab>Centers for Disease Control and Prevention</collab></person-group>.
<article-title>Real-Time RT&#x02013;PCR Panel for Detection 2019-nCoV (US Centers for
Disease Control and Prevention, 2020)</article-title>; <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detection-instructions.html">https://www.cdc.gov/coronavirus/2019-ncov/lab/rt-pcr-detection-instructions.html</uri>
(accessed May 1, <year>2020</year>).</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal" id="cit26"><name><surname>Udugama</surname><given-names>B.</given-names></name>; <name><surname>Kadhiresan</surname><given-names>P.</given-names></name>; <name><surname>Kozlowski</surname><given-names>H. N.</given-names></name>; <name><surname>Malekjahani</surname><given-names>A.</given-names></name>; <name><surname>Osborne</surname><given-names>M.</given-names></name>; <name><surname>Li</surname><given-names>V. Y. C.</given-names></name>; <name><surname>Chen</surname><given-names>H.</given-names></name>; <name><surname>Mubareka</surname><given-names>S.</given-names></name>; <name><surname>Gubbay</surname><given-names>J. B.</given-names></name>; <name><surname>Chan</surname><given-names>W. C. W.</given-names></name>
<article-title>Diagnosing COVID-19: The Disease and Tools for Detection</article-title>. <source>ACS Nano</source>
<year>2020</year>, <volume>14</volume>, <fpage>3822</fpage>&#x02013;<lpage>3835</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.0c02624</pub-id>.<pub-id pub-id-type="pmid">32223179</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal" id="cit27"><name><surname>Chan</surname><given-names>W.C. W.</given-names></name>
<article-title>Nano Research for COVID-19</article-title>. <source>ACS Nano</source>
<year>2020</year>, <volume>14</volume>, <fpage>3719</fpage>&#x02013;<lpage>3720</lpage>. <pub-id pub-id-type="doi">10.1021/acsnano.0c02540</pub-id>.<pub-id pub-id-type="pmid">32227916</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal" id="cit28"><name><surname>Pan</surname><given-names>D.</given-names></name>; <name><surname>Schirra</surname><given-names>C. O.</given-names></name>; <name><surname>Wickline</surname><given-names>S. A.</given-names></name>; <name><surname>Lanza</surname><given-names>G. M.</given-names></name>
<article-title>Multicolor Computed Tomographic Molecular Imaging with Noncrystalline
High-Metal-Density Nanobeacons</article-title>. <source>Contrast Media Mol. Imaging</source>
<year>2014</year>, <volume>9</volume>, <fpage>13</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1002/cmmi.1571</pub-id>.<pub-id pub-id-type="pmid">24470291</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal" id="cit29"><name><surname>Pan</surname><given-names>D.</given-names></name>; <name><surname>Pramanik</surname><given-names>M.</given-names></name>; <name><surname>Senpan</surname><given-names>A.</given-names></name>; <name><surname>Yang</surname><given-names>X.</given-names></name>; <name><surname>Song</surname><given-names>K. H.</given-names></name>; <name><surname>Scott</surname><given-names>M. J.</given-names></name>; <name><surname>Zhang</surname><given-names>H.</given-names></name>; <name><surname>Gaffney</surname><given-names>P. J.</given-names></name>; <name><surname>Wickline</surname><given-names>S. A.</given-names></name>; <name><surname>Wang</surname><given-names>L. V.</given-names></name>; <name><surname>Lanza</surname><given-names>G. M.</given-names></name>
<article-title>Molecular Photo Acoustic Imaging (PAI) with Ligand-Directed Gold
Nanobeacons</article-title>. <source>Angew. Chem., Int. Ed.</source>
<year>2009</year>, <volume>48</volume>, <fpage>4170</fpage>&#x02013;<lpage>4173</lpage>. <pub-id pub-id-type="doi">10.1002/anie.200805947</pub-id>.</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal" id="cit30"><name><surname>Pan</surname><given-names>D.</given-names></name>; <name><surname>Pramanik</surname><given-names>M.</given-names></name>; <name><surname>Senpan</surname><given-names>A.</given-names></name>; <name><surname>Ghosh</surname><given-names>S.</given-names></name>; <name><surname>Wickline</surname><given-names>S. A.</given-names></name>; <name><surname>Wang</surname><given-names>L. V.</given-names></name>; <name><surname>Lanza</surname><given-names>G. M.</given-names></name>
<article-title>Near Infrared Photoacoustic Detection of Sentinel Lymphnodes with Gold
Nanobeacons</article-title>. <source>Biomaterials</source>
<year>2010</year>, <volume>31</volume>, <fpage>4088</fpage>&#x02013;<lpage>4093</lpage>. <pub-id pub-id-type="doi">10.1016/j.biomaterials.2010.01.136</pub-id>.<pub-id pub-id-type="pmid">20172607</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal" id="cit31"><name><surname>Pan</surname><given-names>D.</given-names></name>; <name><surname>Pramanik</surname><given-names>M.</given-names></name>; <name><surname>Senpan</surname><given-names>A.</given-names></name>; <name><surname>Wickline</surname><given-names>S. A.</given-names></name>; <name><surname>Wang</surname><given-names>L. V.</given-names></name>; <name><surname>Lanza</surname><given-names>G. M.</given-names></name>
<article-title>A Facile Synthesis of Novel Self-Assembled Gold Nanorods Designed for
Near-Infrared Imaging</article-title>. <source>J. Nanosci. Nanotechnol.</source>
<year>2010</year>, <volume>10</volume>, <fpage>8118</fpage>&#x02013;<lpage>8123</lpage>. <pub-id pub-id-type="doi">10.1166/jnn.2010.3034</pub-id>.<pub-id pub-id-type="pmid">21121304</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal" id="cit32"><name><surname>Pan</surname><given-names>D.</given-names></name>; <name><surname>Pramanik</surname><given-names>M.</given-names></name>; <name><surname>Senpan</surname><given-names>A.</given-names></name>; <name><surname>Stacy</surname><given-names>A.</given-names></name>; <name><surname>Zhang</surname><given-names>H.</given-names></name>; <name><surname>Wickline</surname><given-names>S. A.</given-names></name>; <name><surname>Wang</surname><given-names>L. V.</given-names></name>; <name><surname>Lanza</surname><given-names>G. M.</given-names></name>
<article-title>Molecular Photoacoustic Imaging of Angiogenesis with Integrin Targeted Gold
Nanobeacons</article-title>. <source>FASEB J.</source>
<year>2011</year>, <volume>25</volume>, <fpage>875</fpage>&#x02013;<lpage>882</lpage>. <pub-id pub-id-type="doi">10.1096/fj.10-171728</pub-id>.<pub-id pub-id-type="pmid">21097518</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal" id="cit33"><name><surname>Zeng</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>Y.</given-names></name>; <name><surname>Zeng</surname><given-names>T.</given-names></name>; <name><surname>Aleisa</surname><given-names>R.</given-names></name>; <name><surname>Qiu</surname><given-names>Z.</given-names></name>; <name><surname>Chen</surname><given-names>Y.</given-names></name>; <name><surname>Huang</surname><given-names>J.</given-names></name>; <name><surname>Wang</surname><given-names>D.</given-names></name>; <name><surname>Yan</surname><given-names>Z.</given-names></name>; <name><surname>Yin</surname><given-names>Y.</given-names></name>
<article-title>Anisotropic Plasmonic Nanostructures for Colorimetric
Sensing</article-title>. <source>Nano Today</source>
<year>2020</year>, <volume>32</volume>, <fpage>100855</fpage><pub-id pub-id-type="doi">10.1016/j.nantod.2020.100855</pub-id>.</mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal" id="cit34"><name><surname>Fraire</surname><given-names>J. C.</given-names></name>; <name><surname>Perez</surname><given-names>L. A.</given-names></name>; <name><surname>Coronado</surname><given-names>E. A.</given-names></name>
<article-title>Rational Design of Plasmonic Nanostructures for Biomolecular Detection:
Interplay between Theory and Experiments</article-title>. <source>ACS Nano</source>
<year>2012</year>, <volume>6</volume>, <fpage>3441</fpage>&#x02013;<lpage>3452</lpage>. <pub-id pub-id-type="doi">10.1021/nn300474p</pub-id>.<pub-id pub-id-type="pmid">22452324</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal" id="cit35"><name><surname>Saha</surname><given-names>K.</given-names></name>; <name><surname>Agasti</surname><given-names>S. S.</given-names></name>; <name><surname>Kim</surname><given-names>C.</given-names></name>; <name><surname>Li</surname><given-names>X.</given-names></name>; <name><surname>Rotello</surname><given-names>V. M.</given-names></name>
<article-title>Gold Nanoparticles in Chemical and Biological Sensing</article-title>. <source>Chem. Rev.</source>
<year>2012</year>, <volume>112</volume>, <fpage>2739</fpage>&#x02013;<lpage>2779</lpage>. <pub-id pub-id-type="doi">10.1021/cr2001178</pub-id>.<pub-id pub-id-type="pmid">22295941</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal" id="cit36"><name><surname>Misra</surname><given-names>S. K.</given-names></name>; <name><surname>Dighe</surname><given-names>K.</given-names></name>; <name><surname>Schwartz-Duval</surname><given-names>A. S.</given-names></name>; <name><surname>Shang</surname><given-names>Z.</given-names></name>; <name><surname>Labriola</surname><given-names>L. T.</given-names></name>; <name><surname>Pan</surname><given-names>D.</given-names></name>
<article-title><italic>In Situ</italic> Plasmonic Generation in Functional
Ionic-Gold-Nanogel Scaffold for Rapid Quantitative Bio-Sensing</article-title>. <source>Biosens. Bioelectron.</source>
<year>2018</year>, <volume>120</volume>, <fpage>77</fpage>&#x02013;<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/j.bios.2018.08.019</pub-id>.<pub-id pub-id-type="pmid">30149216</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal" id="cit37"><name><surname>Li</surname><given-names>Z.</given-names></name>; <name><surname>Askim</surname><given-names>J. R.</given-names></name>; <name><surname>Suslick</surname><given-names>K. S.</given-names></name>
<article-title>The Optoelectronic Nose: Colorimetric and Fluorometric Sensor
Arrays</article-title>. <source>Chem. Rev.</source>
<year>2019</year>, <volume>119</volume>, <fpage>231</fpage>&#x02013;<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1021/acs.chemrev.8b00226</pub-id>.<pub-id pub-id-type="pmid">30207700</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal" id="cit38"><name><surname>Curry</surname><given-names>T.</given-names></name>; <name><surname>Kopelman</surname><given-names>R.</given-names></name>; <name><surname>Shilo</surname><given-names>M.</given-names></name>; <name><surname>Popovtzer</surname><given-names>R.</given-names></name>
<article-title>Multifunctional Theranostic Gold Nanoparticles for Targeted CT Imaging and
Photothermal Therapy</article-title>. <source>Contrast Media Mol. Imaging</source>
<year>2014</year>, <volume>9</volume>, <fpage>53</fpage>&#x02013;<lpage>61</lpage>. <pub-id pub-id-type="doi">10.1002/cmmi.1563</pub-id>.<pub-id pub-id-type="pmid">24470294</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal" id="cit39"><name><surname>Peng</surname><given-names>L.</given-names></name>; <name><surname>Li</surname><given-names>B. L.</given-names></name>; <name><surname>Zhou</surname><given-names>C. W.</given-names></name>; <name><surname>Li</surname><given-names>N. B.</given-names></name>; <name><surname>Setyawati</surname><given-names>M. I.</given-names></name>; <name><surname>Zou</surname><given-names>H. L.</given-names></name>
<article-title>Naked-Eye Recognition: Emerging Gold Nano-Family for Visual
Sensing</article-title>. <source>Appl. Mater. Today.</source>
<year>2018</year>, <volume>11</volume>, <fpage>166</fpage>&#x02013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1016/j.apmt.2018.02.007</pub-id>.</mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal" id="cit40"><name><surname>Mirkin</surname><given-names>C. A.</given-names></name>; <name><surname>Letsinger</surname><given-names>R. L.</given-names></name>; <name><surname>Mucic</surname><given-names>R. C.</given-names></name>; <name><surname>Storhoff</surname><given-names>J. J.</given-names></name>
<article-title>A DNA-Based Method for Rationally Assembling Nanoparticles into Macroscopic
Materials</article-title>. <source>Nature</source>
<year>1996</year>, <volume>382</volume>, <fpage>607</fpage>&#x02013;<lpage>609</lpage>. <pub-id pub-id-type="doi">10.1038/382607a0</pub-id>.<pub-id pub-id-type="pmid">8757129</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal" id="cit41"><name><surname>Elghanian</surname><given-names>R.</given-names></name>; <name><surname>Storhoff</surname><given-names>J. J.</given-names></name>; <name><surname>Mucic</surname><given-names>R. C.</given-names></name>; <name><surname>Letsinger</surname><given-names>R. L.</given-names></name>; <name><surname>Mirkin</surname><given-names>C. A.</given-names></name>
<article-title>Selective Colorimetric Detection of Polynucleotides Based on the
Distance-Dependent Optical Properties of Gold Nanoparticles</article-title>. <source>Science</source>
<year>1997</year>, <volume>277</volume>, <fpage>1078</fpage>&#x02013;<lpage>1081</lpage>. <pub-id pub-id-type="doi">10.1126/science.277.5329.1078</pub-id>.<pub-id pub-id-type="pmid">9262471</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal" id="cit42"><name><surname>Jung</surname><given-names>Y. L.</given-names></name>; <name><surname>Jung</surname><given-names>C.</given-names></name>; <name><surname>Parab</surname><given-names>H.</given-names></name>; <name><surname>Li</surname><given-names>T.</given-names></name>; <name><surname>Park</surname><given-names>H. G.</given-names></name>
<article-title>Direct Colorimetric Diagnosis of Pathogen Infections by Utilizing
Thiol-Labeled PCR Primers and Unmodified Gold Nanoparticles</article-title>. <source>Biosens. Bioelectron.</source>
<year>2010</year>, <volume>25</volume>, <fpage>1941</fpage>&#x02013;<lpage>1946</lpage>. <pub-id pub-id-type="doi">10.1016/j.bios.2010.01.010</pub-id>.<pub-id pub-id-type="pmid">20138499</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal" id="cit43"><name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Rothberg</surname><given-names>L. J.</given-names></name>
<article-title>Label-Free Colorimetric Detection of Specific Sequences in Genomic DNA
Amplified by the Polymerase Chain Reaction</article-title>. <source>J. Am. Chem. Soc.</source>
<year>2004</year>, <volume>126</volume>, <fpage>10958</fpage>&#x02013;<lpage>10961</lpage>. <pub-id pub-id-type="doi">10.1021/ja048749n</pub-id>.<pub-id pub-id-type="pmid">15339181</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal" id="cit44"><name><surname>Li</surname><given-names>H.</given-names></name>; <name><surname>Rothberg</surname><given-names>L.</given-names></name>
<article-title>Colorimetric Detection of DNA Sequences Based on Electrostatic Interactions
with Unmodified Gold Nanoparticles</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<year>2004</year>, <volume>101</volume>, <fpage>14036</fpage>&#x02013;<lpage>14039</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0406115101</pub-id>.<pub-id pub-id-type="pmid">15381774</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal" id="cit45"><name><surname>Shokri</surname><given-names>E.</given-names></name>; <name><surname>Hosseini</surname><given-names>M.</given-names></name>; <name><surname>Davari</surname><given-names>M. D.</given-names></name>; <name><surname>Ganjali</surname><given-names>M. R.</given-names></name>; <name><surname>Peppelenbosch</surname><given-names>M. P.</given-names></name>; <name><surname>Rezaee</surname><given-names>F.</given-names></name>
<article-title>Disulfide-Induced Self-Assembled Targets. A Novel Strategy for the Label
Free Colorimetric Detection of DNAs/RNAs <italic>via</italic> Unmodified Gold
Nanoparticles</article-title>. <source>Sci. Rep.</source>
<year>2017</year>, <volume>7</volume>, <fpage>1</fpage><pub-id pub-id-type="doi">10.1038/srep45837</pub-id>.<pub-id pub-id-type="pmid">28127051</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal" id="cit46"><name><surname>Kim</surname><given-names>H.</given-names></name>; <name><surname>Park</surname><given-names>M.</given-names></name>; <name><surname>Hwang</surname><given-names>J.</given-names></name>; <name><surname>Kim</surname><given-names>J. H.</given-names></name>; <name><surname>Chung</surname><given-names>D.-R.</given-names></name>; <name><surname>Lee</surname><given-names>K.-S.</given-names></name>; <name><surname>Kang</surname><given-names>M.</given-names></name>
<article-title>Development of Label Free Colorimetric Assay for MERS-CoV Using Gold
Nanoparticles</article-title>. <source>ACS Sens.</source>
<year>2019</year>, <volume>4</volume>, <fpage>1306</fpage>&#x02013;<lpage>1312</lpage>. <pub-id pub-id-type="doi">10.1021/acssensors.9b00175</pub-id>.<pub-id pub-id-type="pmid">31062580</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal" id="cit47"><person-group person-group-type="allauthors"><name><surname>Kalantar-Zadeh</surname><given-names>K.</given-names></name>;
<name><surname>Ward</surname><given-names>S. A.</given-names></name>;
<name><surname>Kalantar-Zadeh</surname><given-names>K.</given-names></name>;
<name><surname>El-Omar</surname><given-names>E. M.</given-names></name></person-group>;
<article-title>Considering the Effects of Microbiome and Diet on SARS-CoV-2 Infection:
Nanotechnology Roles</article-title>, <source>ACS Nano</source><year>2020</year> (in press) <pub-id pub-id-type="doi">10.1021/acsnano.0c03402</pub-id>.</mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal" id="cit48"><name><surname>Kostarelos</surname><given-names>K.</given-names></name>
<article-title>Nanoscale Nights of COVID-19</article-title>. <source>Nat. Nanotechnol.</source>
<year>2020</year>, <volume>15</volume>, <fpage>343</fpage>&#x02013;<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1038/s41565-020-0687-4</pub-id>.<pub-id pub-id-type="pmid">32341506</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal" id="cit49"><name><surname>Sportelli</surname><given-names>M. C.</given-names></name>; <name><surname>Izzi</surname><given-names>M.</given-names></name>; <name><surname>Kukushkina</surname><given-names>E. A.</given-names></name>; <name><surname>Hossain</surname><given-names>S. I.</given-names></name>; <name><surname>Picca</surname><given-names>R. A.</given-names></name>; <name><surname>Ditaranto</surname><given-names>N.</given-names></name>; <name><surname>Cioffi</surname><given-names>N.</given-names></name>
<article-title>Can Nanotechnology and Materials Science Help the Fight against
SARS-CoV-2?</article-title>. <source>Nanomaterials</source>
<year>2020</year>, <volume>10</volume>, <fpage>802</fpage><pub-id pub-id-type="doi">10.3390/nano10040802</pub-id>.</mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal" id="cit50"><name><surname>Bellino</surname><given-names>M. G.</given-names></name>; <name><surname>Calvo</surname><given-names>E. J.</given-names></name>; <name><surname>Gordillo</surname><given-names>G.</given-names></name>
<article-title>Adsorption Kinetics of Charged Thiols on Gold Nanoparticles</article-title>. <source>Phys. Chem. Chem. Phys.</source>
<year>2004</year>, <volume>6</volume>, <fpage>424</fpage>&#x02013;<lpage>428</lpage>. <pub-id pub-id-type="doi">10.1039/b312252b</pub-id>.</mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal" id="cit51"><name><surname>Kim</surname><given-names>D.-Y.</given-names></name>; <name><surname>Shinde</surname><given-names>S.</given-names></name>; <name><surname>Saratale</surname><given-names>R.</given-names></name>; <name><surname>Syed</surname><given-names>A.</given-names></name>; <name><surname>Ameen</surname><given-names>F.</given-names></name>; <name><surname>Ghodake</surname><given-names>G.</given-names></name>
<article-title>Spectrophotometric Determination of Fe (III) by Using Casein-Functionalized
Gold Nanoparticles</article-title>. <source>Microchim. Acta</source>
<year>2017</year>, <volume>184</volume>, <fpage>4695</fpage>&#x02013;<lpage>4704</lpage>. <pub-id pub-id-type="doi">10.1007/s00604-017-2520-9</pub-id>.</mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal" id="cit52"><name><surname>Iglesias</surname><given-names>E.</given-names></name>; <name><surname>Prado-Gotor</surname><given-names>R.</given-names></name>
<article-title>Interaction of Gold Nanoparticles Mediated by Captopril and
S-Nitrosocaptopril: The Effect of Manganese Ions in Mild Acid Medium</article-title>. <source>Phys. Chem. Chem. Phys.</source>
<year>2015</year>, <volume>17</volume>, <fpage>644</fpage>&#x02013;<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1039/C4CP03969F</pub-id>.<pub-id pub-id-type="pmid">25407561</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal" id="cit53"><name><surname>Chiu</surname><given-names>N. F.</given-names></name>; <name><surname>Chen</surname><given-names>C. C.</given-names></name>; <name><surname>Yang</surname><given-names>C. D.</given-names></name>; <name><surname>Kao</surname><given-names>Y. S.</given-names></name>; <name><surname>Wu</surname><given-names>W. R.</given-names></name>
<article-title>Enhanced Plasmonic Biosensors of Hybrid Gold Nanoparticle-Graphene
Oxide-Based Label-Free Immunoassay</article-title>. <source>Nanoscale Res. Lett.</source>
<year>2018</year>, <volume>13</volume>, <fpage>152</fpage><pub-id pub-id-type="doi">10.1186/s11671-018-2565-7</pub-id>.<pub-id pub-id-type="pmid">29767347</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal" id="cit54"><name><surname>Misra</surname><given-names>S. K.</given-names></name>; <name><surname>Ostadhossein</surname><given-names>F.</given-names></name>; <name><surname>Daza</surname><given-names>E.</given-names></name>; <name><surname>Johnson</surname><given-names>E. V.</given-names></name>; <name><surname>Pan</surname><given-names>D.</given-names></name>
<article-title>Hyperspectral Imaging Offers Visual and Quantitative Evidence of Drug
Release from Zwitterionic-Phospholipid-Nanocarbon When Concurrently Tracked in 3D
Intracellular Space</article-title>. <source>Adv. Funct. Mater.</source>
<year>2016</year>, <volume>26</volume>, <fpage>8031</fpage><pub-id pub-id-type="doi">10.1002/adfm.201602966</pub-id>.</mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal" id="cit55"><name><surname>Schwartz-Duval</surname><given-names>A. S.</given-names></name>; <name><surname>Misra</surname><given-names>S. K.</given-names></name>; <name><surname>Mukherjee</surname><given-names>P.</given-names></name>; <name><surname>Johnson</surname><given-names>E.</given-names></name>; <name><surname>Acerbo</surname><given-names>A. S.</given-names></name>; <name><surname>Pan</surname><given-names>D.</given-names></name>
<article-title>An Anisotropic Propagation Technique for Synthesizing Hyperbranched
Polyvillic Gold Nanoparticles</article-title>. <source>Nano Res.</source>
<year>2016</year>, <volume>9</volume>, <fpage>2889</fpage>&#x02013;<lpage>2903</lpage>. <pub-id pub-id-type="doi">10.1007/s12274-016-1174-y</pub-id>.</mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal" id="cit56"><name><surname>Bai</surname><given-names>X.</given-names></name>; <name><surname>Shao</surname><given-names>C. Y.</given-names></name>; <name><surname>Han</surname><given-names>X. G.</given-names></name>; <name><surname>Li</surname><given-names>Y. L.</given-names></name>; <name><surname>Guan</surname><given-names>Y. F.</given-names></name>; <name><surname>Deng</surname><given-names>Z. X.</given-names></name>
<article-title>Visual Detection of Sub-Femtomole DNA by a Gold Nanoparticle Seeded
Homogeneous Reduction Assay: Toward a Generalized Sensitivity-Enhancing
Strategy</article-title>. <source>Biosens. Bioelectron.</source>
<year>2010</year>, <volume>25</volume>, <fpage>1984</fpage>&#x02013;<lpage>1988</lpage>. <pub-id pub-id-type="doi">10.1016/j.bios.2010.01.012</pub-id>.<pub-id pub-id-type="pmid">20138749</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal" id="cit57"><name><surname>Ding</surname><given-names>Y.</given-names></name>; <name><surname>Chan</surname><given-names>C. Y.</given-names></name>; <name><surname>Lawrence</surname><given-names>C. E.</given-names></name>
<article-title>Sfold Web Server for Statistical Folding and Rational Design of Nucleic
Acids</article-title>. <source>Nucleic Acids Res.</source>
<year>2004</year>, <volume>32</volume>, <fpage>W135</fpage>&#x02013;<lpage>W141</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkh449</pub-id>.<pub-id pub-id-type="pmid">15215366</pub-id></mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal" id="cit58"><name><surname>Bast&#x000fa;s</surname><given-names>N. G.</given-names></name>; <name><surname>Comenge</surname><given-names>J.</given-names></name>; <name><surname>Puntes</surname><given-names>V.</given-names></name>
<article-title>Kinetically Controlled Seeded Growth Synthesis of Citrate-Stabilized Gold
Nanoparticles of up to 200 nm: Size Focusing <italic>versus</italic> Ostwald
Ripening</article-title>. <source>Langmuir</source>
<year>2011</year>, <volume>27</volume>, <fpage>11098</fpage>&#x02013;<lpage>11105</lpage>. <pub-id pub-id-type="doi">10.1021/la201938u</pub-id>.<pub-id pub-id-type="pmid">21728302</pub-id></mixed-citation></ref></ref-list></back></article>